
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152539378AF1F963053937005850431A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis">
<meta name="citation_author" content="Javier Martín-Escolano">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Ana Ruiz-Molina">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Cristina Rodríguez-Urbistondo">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Carmen Infante-Domínguez">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author" content="Gabriela Abelenda-Alonso">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain">
<meta name="citation_author" content="Gorane Euba">
<meta name="citation_author_institution" content="Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain">
<meta name="citation_author" content="Zaira R Palacios-Baena">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Francisco Arnaiz-Revillas">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain">
<meta name="citation_author" content="Jorge Alba">
<meta name="citation_author_institution" content="Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain">
<meta name="citation_author" content="Alexander Rombauts">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain">
<meta name="citation_author" content="Regino J Rodríguez-Álvarez">
<meta name="citation_author_institution" content="Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain">
<meta name="citation_author" content="Natalia Maldonado">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Claudia González-Rico">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain">
<meta name="citation_author" content="Sonia Santibañez">
<meta name="citation_author_institution" content="Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain">
<meta name="citation_author" content="Marta Carretero-Ledesma">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Laura Merino">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Jordi Carratalá">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain">
<meta name="citation_author" content="Ane Josune Goikoetxea-Agirre">
<meta name="citation_author_institution" content="Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain">
<meta name="citation_author" content="Marta Fernández-Martínez">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain">
<meta name="citation_author" content="José Antonio Oteo">
<meta name="citation_author_institution" content="Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain">
<meta name="citation_author" content="María Carmen Fariñas">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain">
<meta name="citation_author" content="Jesús Rodríguez-Baño">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="Department of Medicine, School of Medicine, University of Seville, Seville, Spain">
<meta name="citation_author" content="José Miguel Cisneros">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Department of Medicine, School of Medicine, University of Seville, Seville, Spain">
<meta name="citation_author" content="Belén Gutiérrez-Gutiérrez">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="Department of Medicine, School of Medicine, University of Seville, Seville, Spain">
<meta name="citation_author" content="Rocío Álvarez-Marín">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author" content="Manuela Aguilar-Guisado">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author" content="Sonsoles Salto-Alejandre">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author" content="Elisa Cordero">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_author_institution" content="Department of Medicine, School of Medicine, University of Seville, Seville, Spain">
<meta name="citation_author" content="Jerónimo Pachón">
<meta name="citation_author_institution" content="Department of Medicine, School of Medicine, University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author" content="Javier Sánchez-Céspedes">
<meta name="citation_author_institution" content="Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain">
<meta name="citation_author_institution" content="CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330495">
<meta name="citation_doi" content="10.1371/journal.pone.0330495">
<meta name="citation_pmid" content="40839611">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/pdf/pone.0330495.pdf">
<meta name="description" content="SARS-CoV-2 RNAemia at diagnosis is associated with mortality. The aims were to identify factors associated with the development of RNAemia. Multicenter COVID-19 cohort study was conducted between January 2020 and May 2023. Demographics, chronic ...">
<meta name="og:title" content="Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="SARS-CoV-2 RNAemia at diagnosis is associated with mortality. The aims were to identify factors associated with the development of RNAemia. Multicenter COVID-19 cohort study was conducted between January 2020 and May 2023. Demographics, chronic ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370080">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330495"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330495.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370080%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370080/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370080/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330495" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 21;20(8):e0330495. doi: <a href="https://doi.org/10.1371/journal.pone.0330495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330495</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mart%C3%ADn-Escolano%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Javier Martín-Escolano</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Javier Martín-Escolano</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation, Formal analysis, Software, Validation, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mart%C3%ADn-Escolano%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Javier Martín-Escolano</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ruiz-Molina%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ana Ruiz-Molina</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ana Ruiz-Molina</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation, Formal analysis, Software, Validation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ruiz-Molina%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana Ruiz-Molina</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-Urbistondo%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Cristina Rodríguez-Urbistondo</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Cristina Rodríguez-Urbistondo</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-Urbistondo%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cristina Rodríguez-Urbistondo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Infante-Dom%C3%ADnguez%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Carmen Infante-Domínguez</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Carmen Infante-Domínguez</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div>Data curation, Project administration, Software, Validation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Infante-Dom%C3%ADnguez%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carmen Infante-Domínguez</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abelenda-Alonso%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Gabriela Abelenda-Alonso</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Gabriela Abelenda-Alonso</span></h3>
<div class="p">
<sup>3</sup>Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abelenda-Alonso%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gabriela Abelenda-Alonso</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Euba%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Gorane Euba</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Gorane Euba</span></h3>
<div class="p">
<sup>4</sup>Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Euba%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gorane Euba</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Palacios-Baena%20ZR%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Zaira R Palacios-Baena</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Zaira R Palacios-Baena</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>5</sup>Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Palacios-Baena%20ZR%22%5BAuthor%5D" class="usa-link"><span class="name western">Zaira R Palacios-Baena</span></a>
</div>
</div>
<sup>2,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arnaiz-Revillas%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Francisco Arnaiz-Revillas</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Francisco Arnaiz-Revillas</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>6</sup>Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arnaiz-Revillas%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francisco Arnaiz-Revillas</span></a>
</div>
</div>
<sup>2,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alba%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jorge Alba</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jorge Alba</span></h3>
<div class="p">
<sup>7</sup>Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alba%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jorge Alba</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rombauts%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Alexander Rombauts</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Alexander Rombauts</span></h3>
<div class="p">
<sup>3</sup>Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rombauts%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander Rombauts</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-%C3%81lvarez%20RJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Regino J Rodríguez-Álvarez</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Regino J Rodríguez-Álvarez</span></h3>
<div class="p">
<sup>4</sup>Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-%C3%81lvarez%20RJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Regino J Rodríguez-Álvarez</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maldonado%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Natalia Maldonado</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Natalia Maldonado</span></h3>
<div class="p">
<sup>5</sup>Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maldonado%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Natalia Maldonado</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonz%C3%A1lez-Rico%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Claudia González-Rico</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Claudia González-Rico</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>6</sup>Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonz%C3%A1lez-Rico%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia González-Rico</span></a>
</div>
</div>
<sup>2,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santiba%C3%B1ez%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Sonia Santibañez</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Sonia Santibañez</span></h3>
<div class="p">
<sup>7</sup>Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santiba%C3%B1ez%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Santibañez</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carretero-Ledesma%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Marta Carretero-Ledesma</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Marta Carretero-Ledesma</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carretero-Ledesma%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marta Carretero-Ledesma</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Merino%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Laura Merino</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Laura Merino</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Data curation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Merino%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura Merino</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carratal%C3%A1%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Jordi Carratalá</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Jordi Carratalá</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>3</sup>Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carratal%C3%A1%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jordi Carratalá</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goikoetxea-Agirre%20AJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Ane Josune Goikoetxea-Agirre</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Ane Josune Goikoetxea-Agirre</span></h3>
<div class="p">
<sup>4</sup>Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goikoetxea-Agirre%20AJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Ane Josune Goikoetxea-Agirre</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fern%C3%A1ndez-Mart%C3%ADnez%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Marta Fernández-Martínez</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Marta Fernández-Martínez</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>6</sup>Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fern%C3%A1ndez-Mart%C3%ADnez%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marta Fernández-Martínez</span></a>
</div>
</div>
<sup>2,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oteo%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">José Antonio Oteo</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">José Antonio Oteo</span></h3>
<div class="p">
<sup>7</sup>Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oteo%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">José Antonio Oteo</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fari%C3%B1as%20MC%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">María Carmen Fariñas</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">María Carmen Fariñas</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>6</sup>Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fari%C3%B1as%20MC%22%5BAuthor%5D" class="usa-link"><span class="name western">María Carmen Fariñas</span></a>
</div>
</div>
<sup>2,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-Ba%C3%B1o%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Jesús Rodríguez-Baño</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Jesús Rodríguez-Baño</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>5</sup>Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div>Funding acquisition, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez-Ba%C3%B1o%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jesús Rodríguez-Baño</span></a>
</div>
</div>
<sup>2,</sup><sup>5,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cisneros%20JM%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">José Miguel Cisneros</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">José Miguel Cisneros</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cisneros%20JM%22%5BAuthor%5D" class="usa-link"><span class="name western">José Miguel Cisneros</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guti%C3%A9rrez-Guti%C3%A9rrez%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Belén Gutiérrez-Gutiérrez</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Belén Gutiérrez-Gutiérrez</span></h3>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>5</sup>Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guti%C3%A9rrez-Guti%C3%A9rrez%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Belén Gutiérrez-Gutiérrez</span></a>
</div>
</div>
<sup>2,</sup><sup>5,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%81lvarez-Mar%C3%ADn%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Rocío Álvarez-Marín</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Rocío Álvarez-Marín</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%81lvarez-Mar%C3%ADn%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rocío Álvarez-Marín</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aguilar-Guisado%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Manuela Aguilar-Guisado</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Manuela Aguilar-Guisado</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div>Funding acquisition, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aguilar-Guisado%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Manuela Aguilar-Guisado</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salto-Alejandre%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Sonsoles Salto-Alejandre</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Sonsoles Salto-Alejandre</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div>Formal analysis, Methodology, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salto-Alejandre%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonsoles Salto-Alejandre</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cordero%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Elisa Cordero</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Elisa Cordero</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div class="p">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div>Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cordero%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisa Cordero</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pach%C3%B3n%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Jerónimo Pachón</span></a><div hidden="hidden" id="id29">
<h3><span class="name western">Jerónimo Pachón</span></h3>
<div class="p">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div class="p">
<sup>9</sup>Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div>Conceptualization, Formal analysis, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pach%C3%B3n%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jerónimo Pachón</span></a>
</div>
</div>
<sup>8,</sup><sup>9,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22S%C3%A1nchez-C%C3%A9spedes%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">Javier Sánchez-Céspedes</span></a><div hidden="hidden" id="id30">
<h3><span class="name western">Javier Sánchez-Céspedes</span></h3>
<div class="p">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div class="p">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div>Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22S%C3%A1nchez-C%C3%A9spedes%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Javier Sánchez-Céspedes</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<div class="cg p">Editor: <span class="name western">Benjamin M Liu</span><sup>10</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div id="aff002">
<sup>2</sup>CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain</div>
<div id="aff003">
<sup>3</sup>Service of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain</div>
<div id="aff004">
<sup>4</sup>Department of Infectious Diseases, Hospital Universitario Cruces, Bizkaia, Spain</div>
<div id="aff005">
<sup>5</sup>Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Instituto de Biomedicina de Sevilla (IBiS)/CSIC/University of Seville, Seville, Spain</div>
<div id="aff006">
<sup>6</sup>Service of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain</div>
<div id="aff007">
<sup>7</sup>Department of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain</div>
<div id="aff008">
<sup>8</sup>Department of Medicine, School of Medicine, University of Seville, Seville, Spain</div>
<div id="aff009">
<sup>9</sup>Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain</div>
<div id="edit1">
<sup>10</sup>Children's National Hospital, George Washington University, UNITED STATES OF AMERICA</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>pachon@us.es</span></p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Javier Martín-Escolano</span></strong>: <span class="role">Data curation, Formal analysis, Software, Validation, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ana Ruiz-Molina</span></strong>: <span class="role">Data curation, Formal analysis, Software, Validation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Cristina Rodríguez-Urbistondo</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Carmen Infante-Domínguez</span></strong>: <span class="role">Data curation, Project administration, Software, Validation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gabriela Abelenda-Alonso</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gorane Euba</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zaira R Palacios-Baena</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jorge Alba</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Alexander Rombauts</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Regino J Rodríguez-Álvarez</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Natalia Maldonado</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Claudia González-Rico</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Sonia Santibañez</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Marta Carretero-Ledesma</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Laura Merino</span></strong>: <span class="role">Data curation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jordi Carratalá</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ane Josune Goikoetxea-Agirre</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Marta Fernández-Martínez</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">José Antonio Oteo</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">María Carmen Fariñas</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jesús Rodríguez-Baño</span></strong>: <span class="role">Funding acquisition, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">José Miguel Cisneros</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Belén Gutiérrez-Gutiérrez</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rocío Álvarez-Marín</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Manuela Aguilar-Guisado</span></strong>: <span class="role">Funding acquisition, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Sonsoles Salto-Alejandre</span></strong>: <span class="role">Formal analysis, Methodology, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Elisa Cordero</span></strong>: <span class="role">Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jerónimo Pachón</span></strong>: <span class="role">Conceptualization, Formal analysis, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Javier Sánchez-Céspedes</span></strong>: <span class="role">Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Benjamin M Liu</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 10; Accepted 2025 Aug 1; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Martín-Escolano et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370080  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40839611/" class="usa-link">40839611</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Objectives</h3>
<p>SARS-CoV-2 RNAemia at diagnosis is associated with mortality. The aims were to identify factors associated with the development of RNAemia.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods</h3>
<p>Multicenter COVID-19 cohort study was conducted between January 2020 and May 2023. Demographics, chronic underlying diseases, symptoms and signs, analytical and radiological variables, cytokines, and neutralizing antibodies were evaluated on admission. RNAemia was the primary endpoint.</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>We included 1011 patients, 392 (38.8%) immunocompromised and 619 (61.2%) immunocompetent. RNAemia occurred in 49.7% and 18.7% (p &lt; 0.001), respectively, being independently associated with 30-day all-cause mortality. In immunocompromised patients, factors independently associated with RNAemia were Alpha and Omicron VOC periods (OR: 1.95 [1.01–3.79]), pneumonia (OR: 1.96 [1.10–3.50]), LDH &gt; 300 UI/L (OR: 1.64 [1.02–2.63]) and neutralizing antibodies absence (OR: 2.51 [1.57–4.00]). In immunocompetent patients, the factors associated with RNAemia were Delta and Omicron VOC periods (OR: 2.27 [1.46–3.52]), lymphocyte count &lt; 1000/µL (OR: 1.81 [1.16–2.80]) and LDH levels &gt; 300 IU/L (OR: 3.99 [2.51–6.36]).</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Immunodeficiency almost tripled SARS-CoV-2 RNAemia. Omicron VOC period, LDH as inflammatory biomarker, and a lower immune response in all patients, neutralizing antibodies absence in immunocompromised and lymphopenia in immunocompetent, and pneumonia in immunocompromised patients were associated with RNAemia.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Introduction</h2>
<p>As of early June 2025, COVID-19 has caused hundreds of millions of infections and millions of deaths worldwide [<a href="#pone.0330495.ref001" class="usa-link" aria-describedby="pone.0330495.ref001">1</a>]. This pandemic has triggered an unprecedented global response from all health systems to advance epidemiological, virological, pathophysiological, clinical, and prognostic knowledge of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Additionally, the availability of resources has allowed the development of new vaccines and antivirals in record time [<a href="#pone.0330495.ref002" class="usa-link" aria-describedby="pone.0330495.ref002">2</a>]. Currently, a high percentage of the world’s population is vaccinated against SARS-CoV-2 (67%) with a complete primary series, although there is high variability depending on the country [<a href="#pone.0330495.ref001" class="usa-link" aria-describedby="pone.0330495.ref001">1</a>]. In Spain, at the time this study was conducted, 79% of the population had been vaccinated using a complete primary series. COVID-19 shows great clinical variability mainly depending on the patient’s baseline condition, ranging from mild cases to critical illness with multiorgan failure and high mortality. Thus, much effort has been put into identifying quick and easy biomarkers of severity at the COVID-19 diagnosis, especially in patients requiring hospital-admission, to implement measures to improve patient management.</p>
<p>SARS-CoV-2 RNAemia, defined as the presence of viral RNA in the bloodstream, has emerged as an independent predictor of severe outcomes in COVID-19 patients [<a href="#pone.0330495.ref003" class="usa-link" aria-describedby="pone.0330495.ref003">3</a>], and support its role as a valid biomarker. Several reports with large cohorts have found a robust association between SARS-CoV-2 RNAemia and adverse clinical outcomes, including mortality [<a href="#pone.0330495.ref004" class="usa-link" aria-describedby="pone.0330495.ref004">4</a>–<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>]. Some of these studies, besides addressing the association of RNAemia with mortality, have also found an association among the presence of RNAemia and plasma viral load with underlying conditions, such as older age and comorbidities, CURB-65 score, or laboratory data such as baseline PaO<sub>2</sub>/FiO<sub>2</sub>, LDH, lymphopenia, C-reactive protein, D-dimer, ferritin, and cytokine (IL-6, IL-10, and IL-15) levels [<a href="#pone.0330495.ref004" class="usa-link" aria-describedby="pone.0330495.ref004">4</a>–<a href="#pone.0330495.ref006" class="usa-link" aria-describedby="pone.0330495.ref006">6</a>]. A study has showed an association of RNAemia at COVID-19 diagnosis with unfavorable outcome, defined as death and/or intensive care admission, in solid organ transplant recipients, besides with mortality in immunocompetent patients [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>].</p>
<p>Other studies have shown an association between severe COVID-19 and immunological factors such as a lack of production of neutralizing antibodies [<a href="#pone.0330495.ref010" class="usa-link" aria-describedby="pone.0330495.ref010">10</a>–<a href="#pone.0330495.ref012" class="usa-link" aria-describedby="pone.0330495.ref012">12</a>] and low levels of IgG [<a href="#pone.0330495.ref013" class="usa-link" aria-describedby="pone.0330495.ref013">13</a>]. Some studies concluded that hospitalized patients have higher titers of neutralizing antibodies (NAb) than non-hospitalized patients [<a href="#pone.0330495.ref010" class="usa-link" aria-describedby="pone.0330495.ref010">10</a>,<a href="#pone.0330495.ref011" class="usa-link" aria-describedby="pone.0330495.ref011">11</a>], but the assayed samples were drawn at heterogeneous times after hospital admission; this may explain the discordant results with other studies evaluating the association of lack of NAb response with fatal outcomes, in which NAb and IgG levels remained in the recovered patients, irrespective of disease severity [<a href="#pone.0330495.ref012" class="usa-link" aria-describedby="pone.0330495.ref012">12</a>]. Additionally, an inverse association between RNAemia and a specific IgG antibody response has been shown in a cohort of patients with COVID-19 with diverse inclusion criteria, suggesting control of SARS-CoV-2 dissemination by the humoral immune response [<a href="#pone.0330495.ref013" class="usa-link" aria-describedby="pone.0330495.ref013">13</a>].</p>
<p>As vaccination rates have increased worldwide, the dynamics of SARS-CoV-2 transmission have undergone a profound shift [<a href="#pone.0330495.ref014" class="usa-link" aria-describedby="pone.0330495.ref014">14</a>]. The wide-scale deployment of vaccines, mainly mRNA-based formulations and vector vaccines, has demonstrated remarkable efficacy in preventing severe COVID-19 [<a href="#pone.0330495.ref002" class="usa-link" aria-describedby="pone.0330495.ref002">2</a>,<a href="#pone.0330495.ref014" class="usa-link" aria-describedby="pone.0330495.ref014">14</a>]; it has also raised questions about the mechanisms for the presence of SARS-CoV-2 RNAemia and its persistence, seen even in vaccinated patients, and its clinical impact. Unravelling the complexities of this association is essential, given the potential implications for the clinical management of these patients.</p>
<p>Previous studies have provided information on the association of RNAemia with the COVID-19 clinical outcome, mostly in immunocompetent patients, and contradictory information on the specific immune response and its association with RNAemia and COVID-19 severity. As other important issue, from the pandemic onset in 2020, SARS-CoV-2 has evolved to different variants of concern (VOC), showing genetic conservation and diversity, and with changes in virulence and pathogenicity [<a href="#pone.0330495.ref015" class="usa-link" aria-describedby="pone.0330495.ref015">15</a>]. In this context, the present study aimed to gain valuable insights into the association of host and virological factors, specific immune response and previous vaccination with the development of SARS-CoV-2 RNAemia at the onset of SARS-CoV-2 disease, both in immunocompromised and immunocompetent patients. The data obtained could generate the necessary knowledge to implement interventions aimed at preventing SARS-CoV-2 RNAemia and improving patient prognosis, especially in more vulnerable populations.</p></section><section id="sec006"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">Research design and participants</h3>
<p>We conducted a prospective, multicenter, and non-interventional study, carried out in six Spanish hospitals, including both immunocompromised, from March 2020 to May 2023, and immunocompetent, from January 2020 to May 2022, patients. Inclusion criteria were: adult age (≥ 18 years), acute COVID-19 confirmed by a positive SARS-CoV-2 reverse transcription-PCR (RT-PCR) test from nasopharyngeal (NP) swabs, availability of blood samples to determine the presence of SARS-CoV-2 RNAemia in the first 24 h after diagnosis, and signed informed consent. Exclusion criteria included: asymptomatic patients, a life expectancy of less than one month, assessed by the physician judgment following the McCabe-Jackson criteria [<a href="#pone.0330495.ref016" class="usa-link" aria-describedby="pone.0330495.ref016">16</a>], and patients who declined to sign the informed consent form. This study was approved by the Ethics Committees of Virgen Rocío and Virgen del Macarena University Hospital (C.I. 0771-N-20 and 1683-N-21) and adhered to the Helsinki Declaration.</p></section><section id="sec008"><h3 class="pmc_sec_title">Clinical data and sample acquisition</h3>
<p>Immediately after enrolment, blood samples to determine the presence of SARS-CoV-2 RNAemia, cytokines, and specific immune response were obtained. Demographics, specific clinical signs and symptoms, and complementary data from standard microbiological, biochemical, and hematological studies were recorded for each patient using a protocol case report form. Disease duration was defined as the number of days from symptom onset to death or hospital discharge. Patients were attended following the decisions of the clinician teams in charge, based on local policies and standard clinical management practices, and were followed up until 30 days after COVID-19 diagnosis or until discharge or death, whichever occurred first. Disease severity at the time of COVID-19 diagnosis and the end of the episode was evaluated using the World Health Organization (WHO) Clinical Progression Scale [<a href="#pone.0330495.ref017" class="usa-link" aria-describedby="pone.0330495.ref017">17</a>].</p></section><section id="sec009"><h3 class="pmc_sec_title">SARS-CoV-2 detection in NP swabs and blood</h3>
<p>For SARS-CoV-2 RNA extraction from plasma samples (collected in EDTA tubes) and NP swabs, a MagNA Pure Compact Nucleic Acid Isolation Kit I (Roche Diagnostics GmbH, Mannheim, Germany) was used according to the manufacturer’s instructions. The RT-PCR assays employed the 2019-nCoV ValuPanel Reagents (LGC Genomics GmbH, Berlin, Germany) in addition to the GoTaq® Probe 1-Step RT-qPCR System (Promega Biotech Ibérica S.L, Madrid, Spain) and were run in a LightCycler 96 Instrument (Roche Diagnostics GmbH, Mannheim, Germany) following the manufacturer’s protocols, with a Ct detection limit of 42. The kit includes internal controls targeting two SARS-CoV-2 nucleocapsid genes and human RNase. SARS-CoV-2 RNAemia quantification was not performed because of it´s not different in immunocompromised <em>vs.</em> immunocompetent patients and its lack of association with unfavorable clinical outcome and/or mortality [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>].</p></section><section id="sec010"><h3 class="pmc_sec_title">Plasma levels of IFN-α and IFN-γ</h3>
<p>Plasma samples were collected and stored at −80 °C before analysis. IFN-α (USCN Life Science &amp; Technology Company, Missouri, TX, USA) and IFN-γ (RayBiotech, Norcross, GA, USA) levels were quantified using ELISA kits following the manufacturer’s instructions as described previously [<a href="#pone.0330495.ref018" class="usa-link" aria-describedby="pone.0330495.ref018">18</a>]. A Multiskan™ GO Microplate Spectrophotometre (Thermo Fisher Scientific, Inc., Waltham, MA, USA) was used to quantify optical density. Relative levels of IFN-α and IFN-γ were analysed using a log/log fit curve with GraphPad Prism 6. These assays, with limits of detection of 3 pg/mL for IFN-α and 2 pg/mL for IFN-γ, were performed in duplicate for each sample. The values used as a reference for healthy, uninfected adults are described in our previous article [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>].</p></section><section id="sec011"><h3 class="pmc_sec_title">Quantification of neutralizing antibodies</h3>
<p>Neutralizing antibodies were evaluated using the viral microneutralization assay. Serum samples were collected from blood tubes with separator gel after centrifugation for 10 minutes at 3000 rpm and 4 °C. In a 96-well polystyrene microplate (Corning, New York, USA), serial dilutions of serum samples were prepared and 1.3 x 10<sup>4</sup> TCID50/mL SARS-CoV-2 (Wuhan-Hu-1) spike pseudotyped lentivirus with a Green Fluorescent Protein reporter of infection (ATCC, Manassas, USA) was added. The mixture was added to microplates containing HEK293T cells expressing human ACE2 and TMPRSS2 (GeneCopoeia, Rockville, MD, USA) that were previously seeded. After incubation at 37 °C for 72 hours, microneutralization by serum was confirmed and quantified. The detection limit for the neutralizing antibodies titer was a 1/3 dilution.</p></section><section id="sec012"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>The primary endpoint was SARS-CoV-2 RNAemia at the time of COVID-19 diagnosis in both immunocompromised and immunocompetent patients. The associations between SARS-CoV-2 RNAemia and clinical conditions, initial symptoms, and immune and inflammatory variables were also evaluated. Descriptive statistics were presented as frequencies (%) or medians with interquartile ranges (IQRs). Continuous variables such as age, Charlson comorbidity index, oxygen saturation (SpO<sub>2</sub>), CURB-65, WHO clinical progression scale, lymphocytes, platelets, creatinine, C-reactive protein, D-dimer, and LDH were dichotomized based on their association with mortality [<a href="#pone.0330495.ref019" class="usa-link" aria-describedby="pone.0330495.ref019">19</a>]. The study was categorized into three periods depending on the predominant SARS-CoV-2 variant of concern (VOC) in Spain [<a href="#pone.0330495.ref020" class="usa-link" aria-describedby="pone.0330495.ref020">20</a>]: i) Alpha from January 2020 to June 27th, 2021; ii) Delta from June 28th to December 19th, 2021; and iii) Omicron from December 20th, 2021 to May 2023. Univariate analysis was conducted to assess the association between the variables and SARS-CoV-2 RNAemia at the time of COVID-19 diagnosis. Statistical tests for between-group comparisons included χ2 or Fisher’s tests, Student’s t-test, Mann-Whitney U test, and Kruskal-Wallis test. Interactions, confusion, and collinearity were thoroughly explored.</p>
<p>The impact of clinical and laboratory variables on 30-day all-cause mortality was first assessed using Cox regression analysis to confirm that SARS-CoV-2 RNAemia was independently associated with mortality in the whole cohort and the immunocompromised and immunocompetent sub-cohorts. Subsequently, the variables associated with the primary endpoint, SARS-CoV-2 RNAemia at COVID-19 diagnosis, and those considered clinically relevant were incorporated into a multiple logistic regression analysis. The variables in the models were selected manually using a backward stepwise process. Sensitivity analyses were performed, including changes in covariates and specific categorizations. The models of variables identified as associated with SARS-CoV-2 RNAemia in the multiple logistic regression analysis were evaluated using the area under the receiver-operating characteristic curve (AUC-ROC), its standard error (under the non-parametric assumption), and the asymptotic significance (being the null hypothesis a true area of 0.5). An AUC-ROC ≥ 0.70 was considered as evidence of good discrimination ability [<a href="#pone.0330495.ref021" class="usa-link" aria-describedby="pone.0330495.ref021">21</a>]. Missing data values (Supplementary <a href="#pone.0330495.s001" class="usa-link">S1 Table</a>) were not imputed in our analysis given to their low number in the variables included in the multivariate analyses. Statistical analyses were performed using SPSS (version 26.0; IBM Corp., Armonk, New York, USA).</p></section></section><section id="sec013"><h2 class="pmc_sec_title">Results</h2>
<p>A whole cohort of 1011 patients with acute COVID-19 were included, consisting of 392 (38.8%) immunocompromised and 619 (61.2%) immunocompetent patient’s sub-cohorts (<a href="#pone.0330495.t001" class="usa-link">Table 1</a>). In the Omicron period were included 377 (37.3%) patients, 78.1% of them immunocompromised, <em>vs.</em> in the Alpha and Delta periods in which were included 438 (43.3%) and 196 (19.4%) patients, 88.6% and 81.6% of them immunocompetent.</p>
<section class="tw xbox font-sm" id="pone.0330495.t001"><h3 class="obj_head">Table 1. Demographics, chronic underlying diseases, clinical characteristics and outcomes of COVID-19 in the entire cohort and in immunocompromised <em>vs.</em> immunocompetent patients.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Variables, N (%)</th>
<th align="left" rowspan="1" colspan="1">Whole cohort N = 1011</th>
<th align="left" rowspan="1" colspan="1">Immunocompromised N = 392</th>
<th align="left" rowspan="1" colspan="1">Immunocompetent <br>N = 619</th>
<th align="left" rowspan="1" colspan="1">P</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Demographics and chronic underlying conditions</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male sex</td>
<td align="left" rowspan="1" colspan="1">629 (62.2)</td>
<td align="left" rowspan="1" colspan="1">234 (59.7)</td>
<td align="left" rowspan="1" colspan="1">395 (63.8)</td>
<td align="left" rowspan="1" colspan="1">0.188</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">64 (54-74)</td>
<td align="left" rowspan="1" colspan="1">65 (55-73)</td>
<td align="left" rowspan="1" colspan="1">64 (53-77)</td>
<td align="left" rowspan="1" colspan="1">0.549</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age &gt; 70 years</td>
<td align="left" rowspan="1" colspan="1">354 (35.0)</td>
<td align="left" rowspan="1" colspan="1">134 (34.2)</td>
<td align="left" rowspan="1" colspan="1">220 (35.5)</td>
<td align="left" rowspan="1" colspan="1">0.659</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Smoking (&gt;10 packets/year)</td>
<td align="left" rowspan="1" colspan="1">101 (10.4)</td>
<td align="left" rowspan="1" colspan="1">61 (15.6)</td>
<td align="left" rowspan="1" colspan="1">40 (6.9)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diabetes mellitus</td>
<td align="left" rowspan="1" colspan="1">276 (27.3)</td>
<td align="left" rowspan="1" colspan="1">111 (28.3)</td>
<td align="left" rowspan="1" colspan="1">165 (26.7)</td>
<td align="left" rowspan="1" colspan="1">0.564</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chronic kidney disease</td>
<td align="left" rowspan="1" colspan="1">163 (16.2)</td>
<td align="left" rowspan="1" colspan="1">112 (28.6)</td>
<td align="left" rowspan="1" colspan="1">51 (8.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index ≥3</td>
<td align="left" rowspan="1" colspan="1">673 (66.6)</td>
<td align="left" rowspan="1" colspan="1">331 (84.4)</td>
<td align="left" rowspan="1" colspan="1">342 (55.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chronic prednisone therapy (&gt;10 mg/day)</td>
<td align="left" rowspan="1" colspan="1">154 (18.2)</td>
<td align="left" rowspan="1" colspan="1">114 (31.1)</td>
<td align="left" rowspan="1" colspan="1">40 (8.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>
<em>Variant of Concern (VOC) periods</em>
</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha</td>
<td align="left" rowspan="1" colspan="1">438 (43.3)</td>
<td align="left" rowspan="1" colspan="1">50 (11.4)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">388 (88.6)<sup>1</sup>
</td>
<td align="left" rowspan="3" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Delta</td>
<td align="left" rowspan="1" colspan="1">196 (19.4)</td>
<td align="left" rowspan="1" colspan="1">36 (18.4)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">160 (81.6)<sup>1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron</td>
<td align="left" rowspan="1" colspan="1">377 (37.3)</td>
<td align="left" rowspan="1" colspan="1">306 (78.1)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">71 (11.5)<sup>1</sup>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>
<em>COVID-19 vaccination in all patients and by VOC periods</em>
</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">All vaccinated patients</td>
<td align="left" rowspan="1" colspan="1">558 (55.2)</td>
<td align="left" rowspan="1" colspan="1">338 (86.2)</td>
<td align="left" rowspan="1" colspan="1">220 (35.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha</td>
<td align="left" rowspan="1" colspan="1">15 (2.7)</td>
<td align="left" rowspan="1" colspan="1">6 (40.0)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">9 (60.0)<sup>2</sup>
</td>
<td align="left" rowspan="3" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Delta</td>
<td align="left" rowspan="1" colspan="1">181 (32.5)</td>
<td align="left" rowspan="1" colspan="1">34 (18.8)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">147 (81.2)<sup>2</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron</td>
<td align="left" rowspan="1" colspan="1">362 (64.9)</td>
<td align="left" rowspan="1" colspan="1">298 (82.3)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">64 (17.7)<sup>2</sup>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Symptoms and signs at diagnosis</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fever</td>
<td align="left" rowspan="1" colspan="1">262 (26.5)</td>
<td align="left" rowspan="1" colspan="1">89 (29.4)</td>
<td align="left" rowspan="1" colspan="1">173 (25.3)</td>
<td align="left" rowspan="1" colspan="1">0.181</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cough</td>
<td align="left" rowspan="1" colspan="1">675 (66.9)</td>
<td align="left" rowspan="1" colspan="1">264 (67.5)</td>
<td align="left" rowspan="1" colspan="1">411 (66.5)</td>
<td align="left" rowspan="1" colspan="1">0.739</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dyspnea</td>
<td align="left" rowspan="1" colspan="1">484 (48.0)</td>
<td align="left" rowspan="1" colspan="1">163 (52.4)</td>
<td align="left" rowspan="1" colspan="1">321 (46.0)</td>
<td align="left" rowspan="1" colspan="1">0.059</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> &lt; 95%</td>
<td align="left" rowspan="1" colspan="1">377 (37.4)</td>
<td align="left" rowspan="1" colspan="1">130 (33.3)</td>
<td align="left" rowspan="1" colspan="1">247 (40.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.032</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pneumonia</td>
<td align="left" rowspan="1" colspan="1">819 (82.0)</td>
<td align="left" rowspan="1" colspan="1">280 (71.4)</td>
<td align="left" rowspan="1" colspan="1">539 (88.8)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CURB-65 ≥ 2</td>
<td align="left" rowspan="1" colspan="1">153 (23.8)</td>
<td align="left" rowspan="1" colspan="1">64 (30.8)</td>
<td align="left" rowspan="1" colspan="1">89 (20.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">WHO clinical progression scale 6–9<sup>3</sup>
</td>
<td align="left" rowspan="1" colspan="1">77 (7.6)</td>
<td align="left" rowspan="1" colspan="1">37 (9.4)</td>
<td align="left" rowspan="1" colspan="1">40 (6.5)</td>
<td align="left" rowspan="1" colspan="1">0.082</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Laboratory findings at diagnosis</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutrophil count &gt;7500/μL</td>
<td align="left" rowspan="1" colspan="1">195 (20.0)</td>
<td align="left" rowspan="1" colspan="1">69 (18.5)</td>
<td align="left" rowspan="1" colspan="1">126 (21.0)</td>
<td align="left" rowspan="1" colspan="1">0.350</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutrophil count (median, IQR) (x1000)</td>
<td align="left" rowspan="1" colspan="1">4.54 (3.2-6.77)</td>
<td align="left" rowspan="1" colspan="1">4.23 (2.60-6.55)</td>
<td align="left" rowspan="1" colspan="1">4.74 (3.48-6.88)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count&lt;1000/µL</td>
<td align="left" rowspan="1" colspan="1">546 (54.9)</td>
<td align="left" rowspan="1" colspan="1">260 (68.8)</td>
<td align="left" rowspan="1" colspan="1">286 (46.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count (median, IQR) (x1000)</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.62-1.40)</td>
<td align="left" rowspan="1" colspan="1">0.71 (0.45-1.16)</td>
<td align="left" rowspan="1" colspan="1">1.04 (0.75-1.48)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Platelets &lt;130 000/μL</td>
<td align="left" rowspan="1" colspan="1">182 (18.3)</td>
<td align="left" rowspan="1" colspan="1">109 (28.8)</td>
<td align="left" rowspan="1" colspan="1">73 (11.8)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Platelets (median, IQR)) (x1000)</td>
<td align="left" rowspan="1" colspan="1">189.0 (142.0-258.0)</td>
<td align="left" rowspan="1" colspan="1">166.5 (124.0-235.2)</td>
<td align="left" rowspan="1" colspan="1">206.0 (155.0-271.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Creatinine &gt;1.3 mg/dL</td>
<td align="left" rowspan="1" colspan="1">280 (28.2)</td>
<td align="left" rowspan="1" colspan="1">179 (47.4)</td>
<td align="left" rowspan="1" colspan="1">101 (16.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Creatinine, mg/dL (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">0.95 (0.74-1.41)</td>
<td align="left" rowspan="1" colspan="1">1.27 (0.87-1.93)</td>
<td align="left" rowspan="1" colspan="1">0.88<br>(0.70-1.11)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C-reactive protein &gt; 100 mg/L</td>
<td align="left" rowspan="1" colspan="1">344 (35.0)</td>
<td align="left" rowspan="1" colspan="1">140 (37.4)</td>
<td align="left" rowspan="1" colspan="1">204 (33.4)</td>
<td align="left" rowspan="1" colspan="1">0.203</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C-reactive protein mg/L (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">66.2 (27.1-132.0)</td>
<td align="left" rowspan="1" colspan="1">75.5 (32.7-135.1)</td>
<td align="left" rowspan="1" colspan="1">63.4 (25.4-129.2)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.018</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D-dimer &gt;600 ng/mL</td>
<td align="left" rowspan="1" colspan="1">463 (55.2)</td>
<td align="left" rowspan="1" colspan="1">199 (67.5)</td>
<td align="left" rowspan="1" colspan="1">264 (48.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D-dimer (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">670 (380-1244)</td>
<td align="left" rowspan="1" colspan="1">860 (520-1650)</td>
<td align="left" rowspan="1" colspan="1">570 (330-1077.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">446 (47.0)</td>
<td align="left" rowspan="1" colspan="1">169 (48.7)</td>
<td align="left" rowspan="1" colspan="1">277 (46.0)</td>
<td align="left" rowspan="1" colspan="1">0.424</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH IU/L (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">291 (232-368)</td>
<td align="left" rowspan="1" colspan="1">295 (227-377)</td>
<td align="left" rowspan="1" colspan="1">288.5 (236-365)</td>
<td align="left" rowspan="1" colspan="1">0.739</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RNAemia</td>
<td align="left" rowspan="1" colspan="1">311 (30.8)</td>
<td align="left" rowspan="1" colspan="1">195 (49.7)</td>
<td align="left" rowspan="1" colspan="1">116 (18.7)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgM positive</td>
<td align="left" rowspan="1" colspan="1">338 (54.1)</td>
<td align="left" rowspan="1" colspan="1">80 (36.9)</td>
<td align="left" rowspan="1" colspan="1">258 (63.2)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgM ng/ml (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">92.4 (57.5-222.2)</td>
<td align="left" rowspan="1" colspan="1">77.4 (42.6-180.7)</td>
<td align="left" rowspan="1" colspan="1">94.5 (60.0-242.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.039</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgG positive</td>
<td align="left" rowspan="1" colspan="1">531 (85.1)</td>
<td align="left" rowspan="1" colspan="1">176 (82.2)</td>
<td align="left" rowspan="1" colspan="1">355 (86.6)</td>
<td align="left" rowspan="1" colspan="1">0.148</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgG ng/ml (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">2088.8 (612.9-3592.9)</td>
<td align="left" rowspan="1" colspan="1">1531.9 (348.8-3180.9)</td>
<td align="left" rowspan="1" colspan="1">2279.0 (750.7-3621.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.014</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutralising antibodies absence</td>
<td align="left" rowspan="1" colspan="1">232 (35.7)</td>
<td align="left" rowspan="1" colspan="1">180 (50.7)</td>
<td align="left" rowspan="1" colspan="1">52 (17.7)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutralising antibodies (GMT, IC95)</td>
<td align="left" rowspan="1" colspan="1">216.1 (175.3-267.1)</td>
<td align="left" rowspan="1" colspan="1">107.0 (77.34-147.6)</td>
<td align="left" rowspan="1" colspan="1">359.4 (272.5-472.9)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-α undetectable</td>
<td align="left" rowspan="1" colspan="1">86 (11.5)</td>
<td align="left" rowspan="1" colspan="1">32 (9.4)</td>
<td align="left" rowspan="1" colspan="1">54 (13.3)</td>
<td align="left" rowspan="1" colspan="1">0.092</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-α pg/mL (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">23.75 (11.76-60.62)</td>
<td align="left" rowspan="1" colspan="1">43.70 (19.59-81.50)</td>
<td align="left" rowspan="1" colspan="1">18.32 (9.28-29.43)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-γ undetectable</td>
<td align="left" rowspan="1" colspan="1">215 (25.2)</td>
<td align="left" rowspan="1" colspan="1">124 (35.0)</td>
<td align="left" rowspan="1" colspan="1">91 (18.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-γ pg/mL (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">69.12 (17.27-182.09)</td>
<td align="left" rowspan="1" colspan="1">52.74 (9.84-84.90)</td>
<td align="left" rowspan="1" colspan="1">106.97 (24.96-272.88)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Treatment</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Antiviral</td>
<td align="left" rowspan="1" colspan="1">269 (27.0)</td>
<td align="left" rowspan="1" colspan="1">179 (47.5)</td>
<td align="left" rowspan="1" colspan="1">90 (14.6)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Remdesivir</td>
<td align="left" rowspan="1" colspan="1">208 (20.9)</td>
<td align="left" rowspan="1" colspan="1">118 (31.3)</td>
<td align="left" rowspan="1" colspan="1">90 (14.6)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tocilizumab</td>
<td align="left" rowspan="1" colspan="1">123 (12.4)</td>
<td align="left" rowspan="1" colspan="1">56 (14.9)</td>
<td align="left" rowspan="1" colspan="1">67 (10.8)</td>
<td align="left" rowspan="1" colspan="1">0.062</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dexamethasone</td>
<td align="left" rowspan="1" colspan="1">558 (62.1)</td>
<td align="left" rowspan="1" colspan="1">216 (57.3)</td>
<td align="left" rowspan="1" colspan="1">342 (65.6)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.011</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Antibiotics</td>
<td align="left" rowspan="1" colspan="1">180 (20.0)</td>
<td align="left" rowspan="1" colspan="1">97 (27.2)</td>
<td align="left" rowspan="1" colspan="1">83 (15.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Outcome</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hospital admission</td>
<td align="left" rowspan="1" colspan="1">969 (95.8)</td>
<td align="left" rowspan="1" colspan="1">358 (91.3)</td>
<td align="left" rowspan="1" colspan="1">611 (98.7)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Length of hospital stay<br>(days, median [IQR])</td>
<td align="left" rowspan="1" colspan="1">7 (4-12)</td>
<td align="left" rowspan="1" colspan="1">8 (5-14.5)</td>
<td align="left" rowspan="1" colspan="1">6 (4-10)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HFNO<sup>4</sup>
</td>
<td align="left" rowspan="1" colspan="1">48 (4.8)</td>
<td align="left" rowspan="1" colspan="1">24 (6.1)</td>
<td align="left" rowspan="1" colspan="1">24 (3.9)</td>
<td align="left" rowspan="1" colspan="1">0.106</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Intensive care unit admission</td>
<td align="left" rowspan="1" colspan="1">76 (7.5)</td>
<td align="left" rowspan="1" colspan="1">32 (8.2)</td>
<td align="left" rowspan="1" colspan="1">44 (7.1)</td>
<td align="left" rowspan="1" colspan="1">0.505</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">WHO clinical progression scale 7–10<sup>3</sup>
</td>
<td align="left" rowspan="1" colspan="1">129 (12.8)</td>
<td align="left" rowspan="1" colspan="1">58 (14.8)</td>
<td align="left" rowspan="1" colspan="1">71 (11.5)</td>
<td align="left" rowspan="1" colspan="1">0.123</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mortality at day + 30</td>
<td align="left" rowspan="1" colspan="1">79 (7.8)</td>
<td align="left" rowspan="1" colspan="1">47 (12.0)</td>
<td align="left" rowspan="1" colspan="1">32 (5.2)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330495.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t001fn001"><p><sup>1</sup>Percentages respect to the patients in each VOC period; <sup>2</sup> Percentages respect to the vaccinated patients in each VOC period; <sup>3</sup>
<a href="https://doi.org/10.1016/S1473-3099(20)30483-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/S1473-3099(20)30483-7</a>; <sup>4</sup> HFNO: High-Flow Nasal Oxygen.</p></div></div></section><p>Regarding the characteristics of COVID-19 at diagnosis in the whole cohort, 96.6% patients were hospital-admitted, 82.0% had pneumonia, 7.9% a WHO clinical progression scale score of 6–9, 30.8% SARS-CoV-2 RNAemia, and the 30-day all-cause mortality was 7.8%. Comparing both sub-cohorts, immunocompromised had been vaccinated against SARS-CoV-2 more frequently than immunocompetent patients (86.2% and 35.5%, p &lt; 0.001). SARS-CoV-2 RNAemia was more frequent in immunocompromised than in immunocompetent (49.7% and 18.7%, p &lt; 0.001) sub-cohorts, as well as immunocompromised patients had higher 30-day all-cause mortality (12.0% and 5.2%, p &lt; 0.001).</p>
<section id="sec014"><h3 class="pmc_sec_title">Variables associated with 30-day all-cause mortality in the whole cohort and immunocompromised and immunocompetent sub-cohorts</h3>
<p>The variables associated with 30-day all-cause mortality in the univariate analysis, in the whole cohort and immunocompromised and immunocompetent sub-cohorts, are detailed in Supplementary <a href="#pone.0330495.s001" class="usa-link">S2 Tables</a>, <a href="#pone.0330495.s001" class="usa-link">S3</a>, and <a href="#pone.0330495.s001" class="usa-link">S4</a>. In dead patients, SARS-CoV-2 RNAemia was more frequent in the whole cohort (65.8% vs. 27.8%; p &lt; 0.001) and the immunocompromised (80.9% vs. 45.5%; p = 0.004) and immunocompetent (43.8% vs. 17.4%, respectively; p = 0.051) sub-cohorts. Regarding the SARS-CoV-2 VOC, mortality was lower in immunocompromised patients included in the Omicron period (7.8%) than in Alpha (28%) and Delta (25.0%) periods (p &lt; 0.001), without differences in the immunocompetent patients.</p>
<p>Subsequently, different Cox multiple regression models were generated to identify independent factors associated with 30-day all-cause mortality for the whole cohort and both sub-cohorts (<a href="#pone.0330495.t002" class="usa-link">Table 2</a>). For the whole cohort, male sex (hazard ratio [HR]: 0.48 [95% CI 0.30–0.75]), Charlson comorbidity index ≥ 3 (HR: 5.43 [2.19–13.46]), dyspnea (HR: 1.81 [1.13–2.92]), CRP &gt; 100 mg/L (HR: 1.70 [1.08–2.67]) and RNAemia (HR: 2.19 [1.37–3.51]) were selected in the final model. In the immunocompromised sub-cohort, independent variables associated with mortality were male sex (HR: 0.37 [0.20–0.68]), age &gt; 70 years (HR: 2.98 [1.65–5.38]), Alpha and Delta VOVC periods (HR: 3.10 [1.74–5.53]), dyspnea (HR: 1.97 [1.06–3.64]) and RNAemia (HR: 3.30 [1.57–6.93]). Finally, in the immunocompetent sub-cohort selected variables were Charlson comorbidity index ≥ 3 (HR: 22.42 [3.06–164.39]) and RNAemia (HR: 2.35 (1.16–4.75), p = 0.018). The administration of remdesivir, tocilizumab, and dexamethasone were not included in the multivariate Cox regression analysis because of they were prescribed, at the criteria of the attending physicians, more frequently in case with severe disease at diagnosis (Supplementary <a href="#pone.0330495.s001" class="usa-link">S5 Table</a>) in the whole cohort and both sub-cohorts.</p>
<section class="tw xbox font-sm" id="pone.0330495.t002"><h4 class="obj_head">Table 2. Variables associated with 30-day all-cause mortality in the whole cohort and in the immunocompromised and immunocompetent sub-cohorts: Multivariate Cox regression analyses.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr><th align="left" colspan="3" rowspan="1">Whole cohort</th></tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>Variables, deaths = 79</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>HR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male sex</td>
<td align="left" rowspan="1" colspan="1">0.48 (0.30-0.75)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index ≥3</td>
<td align="left" rowspan="1" colspan="1">5.43 (2.19-13.46)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dyspnea</td>
<td align="left" rowspan="1" colspan="1">1.81 (1.13-2.92)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.014</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C-reactive protein &gt; 100 mg/L</td>
<td align="left" rowspan="1" colspan="1">1.70 (1.08-2.67)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.021</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RNAemia</td>
<td align="left" rowspan="1" colspan="1">2.19 (1.37-3.51)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">
<strong>Immunocompromised sub-cohort</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>Variables, deaths = 47</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>HR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male sex</td>
<td align="left" rowspan="1" colspan="1">0.37 (0.20-0.68)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age &gt; 70 years</td>
<td align="left" rowspan="1" colspan="1">2.98 (1.65-5.38)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha and Delta VOC periods</td>
<td align="left" rowspan="1" colspan="1">3.10 (1.74-5.53)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dyspnea</td>
<td align="left" rowspan="1" colspan="1">1.97 (1.06-3.64)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.031</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RNAemia</td>
<td align="left" rowspan="1" colspan="1">3.30 (1.57-6.93)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">
<strong>Immunocompetent sub-cohort</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>Variables, deaths = 32</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>HR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index ≥3</td>
<td align="left" rowspan="1" colspan="1">22.42 (3.06-164.39)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RNAemia</td>
<td align="left" rowspan="1" colspan="1">2.35 (1.16-4.75)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.018</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330495.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec015"><h3 class="pmc_sec_title">Variables associated with SARS-CoV-2 RNAemia in the whole cohort and in immunocompromised and immunocompetent sub-cohorts</h3>
<p>Variables associated with SARS-CoV-2 RNAemia in the whole cohort and immunocompromised and immunocompetent sub-cohorts are detailed in <a href="#pone.0330495.t003" class="usa-link">Table 3</a> and Supplementary <a href="#pone.0330495.s001" class="usa-link">S6 Tables</a> and <a href="#pone.0330495.s001" class="usa-link">S8</a>. In the whole cohort (<a href="#pone.0330495.t003" class="usa-link">Table 3</a>), patients with SARS-CoV-2 RNAemia had higher frequencies of immunocompromise (p &lt; 0.001) and RNAemia was more frequent in the Omicron than Alpha or Delta VOC periods (p &lt; 0.001). Multiple logistic regression analysis of the whole cohort (<a href="#pone.0330495.t004" class="usa-link">Table 4</a>) showed that immunocompromise (odds ratio [OR]: 3.66 [2.47–5.44]), lymphocyte count &lt; 1000/µL (OR: 1.60 [1.16–2.19]) and LDH &gt; 300 UI/L (OR: 2.51 [1.84–3.42]) were independently associated with the presence of SARS-CoV-2 RNAemia at COVID-19 diagnosis. RNAemia seems independently associated with the Omicron VOC period, but this effect was no longer present (OR: 1.44 [0.97–2.15]) when SpO<sub>2</sub> was removed from the model. The AUC-ROC were 0.763 (0.731−0795, p &lt; 0.001) and 0.759 (0.726–0.791, p &lt; 0.001) for both models (Supplementary <a href="#pone.0330495.s001" class="usa-link">S1 Fig</a>).</p>
<section class="tw xbox font-sm" id="pone.0330495.t003"><h4 class="obj_head">Table 3. Demographics, chronic underlying diseases, clinical characteristics and outcomes of patients in the whole cohort with <em>vs.</em> without SARS-CoV-2 RNAemia at COVID-19 diagnosis.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Variables</th>
<th align="left" rowspan="1" colspan="1">Whole cohort N = 1011</th>
<th align="left" rowspan="1" colspan="1">RNAemia N = 311 (30.8%)</th>
<th align="left" rowspan="1" colspan="1">No RNAemia N = 700 (69.2%)</th>
<th align="left" rowspan="1" colspan="1">P</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Demographics and chronic underlying conditions</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male sex</td>
<td align="left" rowspan="1" colspan="1">629 (62.2)</td>
<td align="left" rowspan="1" colspan="1">200 (64.3)</td>
<td align="left" rowspan="1" colspan="1">429 (61.3)</td>
<td align="left" rowspan="1" colspan="1">0.360</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">64 (54-74)</td>
<td align="left" rowspan="1" colspan="1">66 (57-74)</td>
<td align="left" rowspan="1" colspan="1">63 (52-75)</td>
<td align="left" rowspan="1" colspan="1">0.081</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age &gt; 70 years</td>
<td align="left" rowspan="1" colspan="1">354 (35.0)</td>
<td align="left" rowspan="1" colspan="1">111 (35.7)</td>
<td align="left" rowspan="1" colspan="1">243 (34.7)</td>
<td align="left" rowspan="1" colspan="1">0.764</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Smoking (&gt;10 packets/year)</td>
<td align="left" rowspan="1" colspan="1">101 (10.4)</td>
<td align="left" rowspan="1" colspan="1">38 (12.3)</td>
<td align="left" rowspan="1" colspan="1">63 (9.5)</td>
<td align="left" rowspan="1" colspan="1">0.178</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diabetes mellitus</td>
<td align="left" rowspan="1" colspan="1">276 (27.3)</td>
<td align="left" rowspan="1" colspan="1">93 (29.9)</td>
<td align="left" rowspan="1" colspan="1">183 (26.1)</td>
<td align="left" rowspan="1" colspan="1">0.215</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chronic kidney disease</td>
<td align="left" rowspan="1" colspan="1">163 (16.2)</td>
<td align="left" rowspan="1" colspan="1">73 (23.6)</td>
<td align="left" rowspan="1" colspan="1">90 (12.9)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index ≥3</td>
<td align="left" rowspan="1" colspan="1">673 (66.6)</td>
<td align="left" rowspan="1" colspan="1">237 (76.2)</td>
<td align="left" rowspan="1" colspan="1">436 (62.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chronic prednisone therapy (&gt;10 mg/day)</td>
<td align="left" rowspan="1" colspan="1">154 (18.2)</td>
<td align="left" rowspan="1" colspan="1">71 (25.3)</td>
<td align="left" rowspan="1" colspan="1">83 (14.7)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Immunocompromise</td>
<td align="left" rowspan="1" colspan="1">392 (38.8)</td>
<td align="left" rowspan="1" colspan="1">195 (62.7)</td>
<td align="left" rowspan="1" colspan="1">197 (28.1)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>
<em>Variant of Concern (VOC) periods</em>
</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha</td>
<td align="left" rowspan="1" colspan="1">438 (43.3)</td>
<td align="left" rowspan="1" colspan="1">87 (19.9)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">351 (80.1)<sup>1</sup>
</td>
<td align="left" rowspan="3" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Delta</td>
<td align="left" rowspan="1" colspan="1">196 (19.4)</td>
<td align="left" rowspan="1" colspan="1">52 (26.5)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">144 (73.5)<sup>1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron</td>
<td align="left" rowspan="1" colspan="1">377 (37.3)</td>
<td align="left" rowspan="1" colspan="1">172 (45.6)<sup>1</sup>
</td>
<td align="left" rowspan="1" colspan="1">205 (54.4)<sup>1</sup>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>
<em>COVID-19 vaccination in all patients and by VOC periods</em>
</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">All vaccinated patients</td>
<td align="left" rowspan="1" colspan="1">558 (55.2)</td>
<td align="left" rowspan="1" colspan="1">220 (70.7)</td>
<td align="left" rowspan="1" colspan="1">338 (48.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha</td>
<td align="left" rowspan="1" colspan="1">15 (2.7)</td>
<td align="left" rowspan="1" colspan="1">5 (33.3)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">10 (66.7)<sup>2</sup>
</td>
<td align="left" rowspan="3" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Delta</td>
<td align="left" rowspan="1" colspan="1">181 (32.4)</td>
<td align="left" rowspan="1" colspan="1">49 (27.1)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">132 (72.9)<sup>2</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron</td>
<td align="left" rowspan="1" colspan="1">362 (64.9)</td>
<td align="left" rowspan="1" colspan="1">166 (45.9)<sup>2</sup>
</td>
<td align="left" rowspan="1" colspan="1">196 (54.1)<sup>2</sup>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Symptoms and signs at diagnosis</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fever</td>
<td align="left" rowspan="1" colspan="1">262 (26.5)</td>
<td align="left" rowspan="1" colspan="1">89 (29.4)</td>
<td align="left" rowspan="1" colspan="1">173 (25.3)</td>
<td align="left" rowspan="1" colspan="1">0.181</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cough</td>
<td align="left" rowspan="1" colspan="1">675 (66.9)</td>
<td align="left" rowspan="1" colspan="1">224 (72.3)</td>
<td align="left" rowspan="1" colspan="1">451 (64.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.016</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dyspnoea</td>
<td align="left" rowspan="1" colspan="1">484 (48.0)</td>
<td align="left" rowspan="1" colspan="1">163 (52.4)</td>
<td align="left" rowspan="1" colspan="1">321 (46.0)</td>
<td align="left" rowspan="1" colspan="1">0.059</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> &lt; 95%</td>
<td align="left" rowspan="1" colspan="1">377 (37.4)</td>
<td align="left" rowspan="1" colspan="1">142 (45.7)</td>
<td align="left" rowspan="1" colspan="1">235 (33.8)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pneumonia</td>
<td align="left" rowspan="1" colspan="1">819 (82.0)</td>
<td align="left" rowspan="1" colspan="1">258 (84.0)</td>
<td align="left" rowspan="1" colspan="1">561 (81.1)</td>
<td align="left" rowspan="1" colspan="1">0.260</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CURB-65 ≥ 2</td>
<td align="left" rowspan="1" colspan="1">153 (23.8)</td>
<td align="left" rowspan="1" colspan="1">64 (30.8)</td>
<td align="left" rowspan="1" colspan="1">89 (20.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">WHO clinical progression scale 6–9<sup>3</sup>
</td>
<td align="left" rowspan="1" colspan="1">77 (7.6)</td>
<td align="left" rowspan="1" colspan="1">46 (14.8)</td>
<td align="left" rowspan="1" colspan="1">31 (4.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Laboratory findings at diagnosis</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutrophil count &gt;7500/μL</td>
<td align="left" rowspan="1" colspan="1">195 (20.0)</td>
<td align="left" rowspan="1" colspan="1">66 (21.9)</td>
<td align="left" rowspan="1" colspan="1">129 (19.2)</td>
<td align="left" rowspan="1" colspan="1">0.320</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutrophil count (median, IQR) (x1000)</td>
<td align="left" rowspan="1" colspan="1">4.5 (3.2-6.8)</td>
<td align="left" rowspan="1" colspan="1">4.3 (2.9-7.1)</td>
<td align="left" rowspan="1" colspan="1">4.6 (3.3-6.6)</td>
<td align="left" rowspan="1" colspan="1">0.265</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count&lt;1000/µL</td>
<td align="left" rowspan="1" colspan="1">546 (54.9)</td>
<td align="left" rowspan="1" colspan="1">211 (68.5)</td>
<td align="left" rowspan="1" colspan="1">335 (48.8)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count (median, IQR) (x1000)</td>
<td align="left" rowspan="1" colspan="1">0.9 (0.6-1.4)</td>
<td align="left" rowspan="1" colspan="1">0.7 (0.5-1.2)</td>
<td align="left" rowspan="1" colspan="1">1.0 (0.7-1.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Platelets &lt;130 000/μL</td>
<td align="left" rowspan="1" colspan="1">182 (18.3)</td>
<td align="left" rowspan="1" colspan="1">75 (24.4)</td>
<td align="left" rowspan="1" colspan="1">107 (15.6)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Platelets (median, IQR)) (x1000)</td>
<td align="left" rowspan="1" colspan="1">189.0 (142.0-258.0)</td>
<td align="left" rowspan="1" colspan="1">172.5 (131.0-236.7)</td>
<td align="left" rowspan="1" colspan="1">201.0 (148.0-268.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Creatinine &gt;1.3 mg/dL</td>
<td align="left" rowspan="1" colspan="1">280 (28.2)</td>
<td align="left" rowspan="1" colspan="1">126 (41.2)</td>
<td align="left" rowspan="1" colspan="1">154 (22.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Creatinine, mg/dL (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">0.9 (0.7-1.4)</td>
<td align="left" rowspan="1" colspan="1">1.1 (0.8-1.7)</td>
<td align="left" rowspan="1" colspan="1">0.9 (0.7-1.2)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C-reactive protein &gt; 100 mg/L</td>
<td align="left" rowspan="1" colspan="1">344 (35.0)</td>
<td align="left" rowspan="1" colspan="1">145 (47.7)</td>
<td align="left" rowspan="1" colspan="1">199 (29.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">C-reactive protein mg/L (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">66.2 (27.1-132.0)</td>
<td align="left" rowspan="1" colspan="1">94.1 (47.1-158.3)</td>
<td align="left" rowspan="1" colspan="1">56.8 (22.2-112.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D-dimer &gt;600 ng/mL</td>
<td align="left" rowspan="1" colspan="1">463 (55.2)</td>
<td align="left" rowspan="1" colspan="1">157 (63.3)</td>
<td align="left" rowspan="1" colspan="1">306 (51.8)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">D-dimer (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">670.0 (380.0-1244.0)</td>
<td align="left" rowspan="1" colspan="1">750.0 (472.5-1355.0)</td>
<td align="left" rowspan="1" colspan="1">640.0 (340.0-1150.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">446 (47.0)</td>
<td align="left" rowspan="1" colspan="1">182 (62.1)</td>
<td align="left" rowspan="1" colspan="1">264 (40.2)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH IU/L (median [IQR])</td>
<td align="left" rowspan="1" colspan="1">291.0 (232.0-368.0)</td>
<td align="left" rowspan="1" colspan="1">328.0 (257.0-439.5)</td>
<td align="left" rowspan="1" colspan="1">276.0 (227.0-344.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgM positive</td>
<td align="left" rowspan="1" colspan="1">338 (54.1)</td>
<td align="left" rowspan="1" colspan="1">85 (42.9)</td>
<td align="left" rowspan="1" colspan="1">253 (59.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgM ng/ml (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">92.4 (57.5-222.2)</td>
<td align="left" rowspan="1" colspan="1">86.2 (53.2-181.4)</td>
<td align="left" rowspan="1" colspan="1">94.1 (59.5-223.4)</td>
<td align="left" rowspan="1" colspan="1">0.364</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgG positive</td>
<td align="left" rowspan="1" colspan="1">531 (85.1)</td>
<td align="left" rowspan="1" colspan="1">164 (83.2)</td>
<td align="left" rowspan="1" colspan="1">367 (85.9)</td>
<td align="left" rowspan="1" colspan="1">0.379</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IgG ng/ml<br>(median, IQR)</td>
<td align="left" rowspan="1" colspan="1">2088.8 (612.9-3592.9)</td>
<td align="left" rowspan="1" colspan="1">1748.0 (490.3-3423.7)</td>
<td align="left" rowspan="1" colspan="1">2128.9 (743.2-3688.2)</td>
<td align="left" rowspan="1" colspan="1">0.093</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutralising antibodies absence</td>
<td align="left" rowspan="1" colspan="1">232 (35.7)</td>
<td align="left" rowspan="1" colspan="1">128 (51.0)</td>
<td align="left" rowspan="1" colspan="1">104 (26.1)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutralising antibodies (GMT, IC95)</td>
<td align="left" rowspan="1" colspan="1">216.1 (174.2-264.9)</td>
<td align="left" rowspan="1" colspan="1">140.7 (99.11-198.0)</td>
<td align="left" rowspan="1" colspan="1">258.7 (201.4-337.3)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.016</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-α undetectable</td>
<td align="left" rowspan="1" colspan="1">86 (11.5)</td>
<td align="left" rowspan="1" colspan="1">24 (9.8)</td>
<td align="left" rowspan="1" colspan="1">62 (12.4)</td>
<td align="left" rowspan="1" colspan="1">0.296</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-α pg/mL (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">23.75 (11.76-60.62)</td>
<td align="left" rowspan="1" colspan="1">38.91 (17.44-77.06)</td>
<td align="left" rowspan="1" colspan="1">20.84 (10.85-45.74)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-γ undetectable</td>
<td align="left" rowspan="1" colspan="1">215 (25.2)</td>
<td align="left" rowspan="1" colspan="1">80 (29.0)</td>
<td align="left" rowspan="1" colspan="1">135 (23.4)</td>
<td align="left" rowspan="1" colspan="1">0.081</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IFN-γ pg/mL (median, IQR)</td>
<td align="left" rowspan="1" colspan="1">69.12 (17.27-182.09)</td>
<td align="left" rowspan="1" colspan="1">60.29 (12.80-147.21)</td>
<td align="left" rowspan="1" colspan="1">72.5 (22.12-226.21)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.007</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Treatment</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Antiviral</td>
<td align="left" rowspan="1" colspan="1">269 (27.0)</td>
<td align="left" rowspan="1" colspan="1">113 (37.7)</td>
<td align="left" rowspan="1" colspan="1">156 (22.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Remdesivir</td>
<td align="left" rowspan="1" colspan="1">208 (20.9)</td>
<td align="left" rowspan="1" colspan="1">90 (30.0)</td>
<td align="left" rowspan="1" colspan="1">118 (17.0)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tocilizumab</td>
<td align="left" rowspan="1" colspan="1">123 (12.4)</td>
<td align="left" rowspan="1" colspan="1">77 (25.7)</td>
<td align="left" rowspan="1" colspan="1">46 (6.6)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dexamethasone</td>
<td align="left" rowspan="1" colspan="1">558 (62.1)</td>
<td align="left" rowspan="1" colspan="1">214 (74.0)</td>
<td align="left" rowspan="1" colspan="1">344 (56.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Antibiotics</td>
<td align="left" rowspan="1" colspan="1">180 (20.0)</td>
<td align="left" rowspan="1" colspan="1">77 (27.9)</td>
<td align="left" rowspan="1" colspan="1">103 (16.5)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<strong>Outcome</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hospital admission</td>
<td align="left" rowspan="1" colspan="1">969 (95.8)</td>
<td align="left" rowspan="1" colspan="1">299 (96.1)</td>
<td align="left" rowspan="1" colspan="1">670 (95.7)</td>
<td align="left" rowspan="1" colspan="1">0.753</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Length of hospital stay (days, median [IQR])</td>
<td align="left" rowspan="1" colspan="1">7 (4-12)</td>
<td align="left" rowspan="1" colspan="1">10 (5-15)</td>
<td align="left" rowspan="1" colspan="1">6 (4-10)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HFNO<sup>4</sup>
</td>
<td align="left" rowspan="1" colspan="1">48 (4.8)</td>
<td align="left" rowspan="1" colspan="1">31 (10.0)</td>
<td align="left" rowspan="1" colspan="1">17 (2.4)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Intensive care unit admission</td>
<td align="left" rowspan="1" colspan="1">76 (7.5)</td>
<td align="left" rowspan="1" colspan="1">42 (13.6)</td>
<td align="left" rowspan="1" colspan="1">34 (4.9)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">WHO clinical progression scale 7–10<sup>3</sup>
</td>
<td align="left" rowspan="1" colspan="1">129 (12.8)</td>
<td align="left" rowspan="1" colspan="1">75 (24.1)</td>
<td align="left" rowspan="1" colspan="1">54 (7.7)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mortality at day + 30</td>
<td align="left" rowspan="1" colspan="1">79 (7.8)</td>
<td align="left" rowspan="1" colspan="1">52 (16.7)</td>
<td align="left" rowspan="1" colspan="1">27 (3.9)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330495.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t003fn001"><p><sup>1</sup>Percentages respect to the patients in each VOC period; <sup>2</sup> Percentages respect to the vaccinated patients in each VOC period; <sup>3</sup>
<a href="https://doi.org/10.1016/S1473-3099(20)30483-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/S1473-3099(20)30483-7</a>; <sup>4</sup> HFNO: High-Flow Nasal Oxygen.</p></div></div></section><section class="tw xbox font-sm" id="pone.0330495.t004"><h4 class="obj_head">Table 4. Risk factors associated with the presence of RNAemia in the whole cohort and in the immunocompromised and immunocompetent sub-cohorts: Multivariate logistic regression analyses.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr><th align="left" colspan="3" rowspan="1">
<em>Whole cohort</em>
</th></tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>Model A, N = 945</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>OR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Immunocompromise</td>
<td align="left" rowspan="1" colspan="1">3.74 (2.51-5.58)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron period</td>
<td align="left" rowspan="1" colspan="1">1.55 (1.03-2.32)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.035</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> &lt; 95%</td>
<td align="left" rowspan="1" colspan="1">1.67 (1.21-2.30)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count&lt;1000/µL</td>
<td align="left" rowspan="1" colspan="1">1.54 (1.12-2.11)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.008</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">2.25 (1.64-3.09)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>Model B, N = 948</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>OR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Immunocompromise</td>
<td align="left" rowspan="1" colspan="1">3.66 (2.47-5.44)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Omicron VOC period</td>
<td align="left" rowspan="1" colspan="1">1.44 (0.97-2.15)</td>
<td align="left" rowspan="1" colspan="1">0.071</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count&lt;1000/µL</td>
<td align="left" rowspan="1" colspan="1">1.60 (1.16-2.19)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">2.51 (1.84-3.42)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">
<strong>Immunocompromised sub-cohort</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>N = 317</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>OR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alpha and Omicron VOC periods</td>
<td align="left" rowspan="1" colspan="1">1.95 (1.01-3.79)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.048</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pneumonia</td>
<td align="left" rowspan="1" colspan="1">1.96 (1.10-3.50)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.023</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">1.64 (1.02-2.63)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.041</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Neutralizing antibodies absence</td>
<td align="left" rowspan="1" colspan="1">2.51 (1.57-4.00)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">
<strong>Immunocompetent sub-cohort</strong>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>
<em>N = 605</em>
</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>OR (95% CI)</strong>
</td>
<td align="left" rowspan="1" colspan="1">
<strong>P</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Delta and Omicron VOC periods</td>
<td align="left" rowspan="1" colspan="1">2.27 (1.46-3.52)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lymphocyte count&lt;1000/µL</td>
<td align="left" rowspan="1" colspan="1">1.81 (1.16-2.80)</td>
<td align="left" rowspan="1" colspan="1">
<strong>0.008</strong>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">LDH &gt; 300 IU/L</td>
<td align="left" rowspan="1" colspan="1">3.99 (2.51-6.36)</td>
<td align="left" rowspan="1" colspan="1">
<strong>&lt;0.001</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330495.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>In the immunocompromised sub-cohort (Supplementary <a href="#pone.0330495.s001" class="usa-link">S6 Table</a>), SARS-CoV-2 RNAemia was more frequent in the Alpha or Omicron than in Delta VOC periods (p = 0.05). Multiple logistic regression analysis (<a href="#pone.0330495.t004" class="usa-link">Table 4</a>) identified the Alpha and Omicron VOC periods (OR: 1.95 [1.01–3.79]), pneumonia (OR: 1.96 [1.10–3.50]), LDH &gt; 300 UI/L (OR: 1.64 [1.02–2.63]) and the absence of neutralizing antibodies (OR: 2.51 [1.57–4.00]) as independent factors associated with the presence of SARS-CoV-2 RNAemia at COVID-19 diagnosis, with an AUC-ROC of 0.678 (0.619–0.737, p &lt; 0.001) (Supplementary <a href="#pone.0330495.s001" class="usa-link">S1 Fig</a>).</p>
<p>The immunocompromised sub-cohort includes different types of immunocompromise (Supplementary <a href="#pone.0330495.s001" class="usa-link">S3 Table</a>) without difference in mortality rates (p = 0.429). However, RNAemia was more frequent (p = 0.045) in hematological malignancies (HM) and solid organ transplant recipients (SOT) than in solid neoplasia (SN) and other causes of immunocompromise (Supplementary <a href="#pone.0330495.s001" class="usa-link">S6 Table</a>). As a sensitivity analysis, we next analyzed factors associated with the presence of RNAemia in these different immunocompromised patients (Supplementary <a href="#pone.0330495.s001" class="usa-link">S7 Table</a>). Pneumonia (OR: 2.53 [1.18–5.40]) in HM, pneumonia (OR: 2.50 [1.15–5.47]) and neutralizing antibodies absence (OR: 2.81 [1.48–5.35]) in SOT, and neutralizing antibodies absence (OR: 5.37 [1.32–21.87]) in SN were factors independently associated with RNAemia.</p>
<p>SARS-CoV-2 RNAemia in the immunocompetent sub-cohort (Supplementary <a href="#pone.0330495.s001" class="usa-link">S8 Table</a>) was more frequent in the Delta and Omicron than in Alpha VOC periods (p = 0.003). Factors independently associated with RNAemia were Delta and Omicron VOC periods (OR: 2.27 [1.46–3.52]), lymphocyte count &lt; 1000/µL (OR: 1.81 [1.16–2.80]) and LDH levels &gt; 300 IU/L (OR: 3.99 [2.51–6.36]) (<a href="#pone.0330495.t004" class="usa-link">Table 4</a>). The model has an AUC-ROC of 0.720 (0.670–0.770, p &lt; 0.001) (Supplementary <a href="#pone.0330495.s001" class="usa-link">S1 Fig</a>).</p></section></section><section id="sec016"><h2 class="pmc_sec_title">Discussion</h2>
<p>The present study identifies factors associated with the SARS-CoV-2 RNAemia at the COVID-19 diagnosis. Regarding the host underlying condition, diseases causing immunocompromise are the most prominent ones in the whole cohort. Among the virologic factors, patients included in the Omicron VOC period have more RNAemia, both in immunocompromised and immunocompetent patients. Pneumonia in immunocompromised patients, high serum LDH levels in all patients, and markers of lower immune response, neutralizing antibodies absence in immunocompromised and lymphopenia in immunocompetent patients, were also associated with RNAemia.</p>
<p>In the present study, as a first analysis, we confirmed that SARS-CoV-2 RNAemia was an independent risk factor for 30-day all-cause mortality in both immunocompromised and immunocompetent individuals. Our group and others have previously evaluated the relevance of RNAemia in monitoring COVID-19 patients. The rate of SARS-CoV-2 RNAemia is highly variable in the literature, ranging from 10% to over 60% [<a href="#pone.0330495.ref003" class="usa-link" aria-describedby="pone.0330495.ref003">3</a>–<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>,<a href="#pone.0330495.ref018" class="usa-link" aria-describedby="pone.0330495.ref018">18</a>,<a href="#pone.0330495.ref022" class="usa-link" aria-describedby="pone.0330495.ref022">22</a>–<a href="#pone.0330495.ref030" class="usa-link" aria-describedby="pone.0330495.ref030">30</a>], which could be explained by the differences found among the demographic characteristics, underlying conditions, and time from symptom onset. The rate of RNAemia in this study was in line with previous reports by our group and colleagues in both immunocompetent [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>,<a href="#pone.0330495.ref022" class="usa-link" aria-describedby="pone.0330495.ref022">22</a>,<a href="#pone.0330495.ref023" class="usa-link" aria-describedby="pone.0330495.ref023">23</a>] and immunocompromised patients [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>,<a href="#pone.0330495.ref018" class="usa-link" aria-describedby="pone.0330495.ref018">18</a>]. In addition, despite most patients being fully vaccinated since June 2021, especially in the immunocompromised group, the incidence of RNAemia remained elevated at close to four out of ten cases. The mortality rate in our study was lower than that in previous studies conducted by our group in non-vaccinated immunocompromised and immunocompetent patients [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>,<a href="#pone.0330495.ref022" class="usa-link" aria-describedby="pone.0330495.ref022">22</a>], which is in line with other studies in pre-vaccination cohorts [<a href="#pone.0330495.ref006" class="usa-link" aria-describedby="pone.0330495.ref006">6</a>,<a href="#pone.0330495.ref031" class="usa-link" aria-describedby="pone.0330495.ref031">31</a>]. As previously observed in a cohort of 408 immunocompetent individuals and 47 solid organ transplant recipients [<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>], RNAemia was independently associated with mortality in all immunocompetent or immunocompromised patients.</p>
<p>The increased frequency of RNAemia and its strong association with mortality in immunocompromised patients may reflect impaired viral control and persistent systemic inflammation, which together could facilitate viral dissemination. Weak immune responses may not efficiently eliminate viral replication or bloodstream dissemination. Another associated factor is LDH, an enzyme involved in inflammatory processes, which in turn leads to tissue damage. This could explain the bloodstream release and dissemination of the virus [<a href="#pone.0330495.ref032" class="usa-link" aria-describedby="pone.0330495.ref032">32</a>,<a href="#pone.0330495.ref033" class="usa-link" aria-describedby="pone.0330495.ref033">33</a>]. Moreover, higher LDH levels have been associated with severity of COVID-19 pneumonia [<a href="#pone.0330495.ref034" class="usa-link" aria-describedby="pone.0330495.ref034">34</a>]. In addition, in immunocompetent patients, lymphopenia was independently associated with RNAemia, which is explained by the implication of lymphocytes in the innate immune response, including lymphoid cells type 1 as the first line of defense against viruses. In a previous Spanish nationwide study in a cohort of 4035 patients with COVID-19, lymphopenia was more common in patients who died, being an important predictor of mortality [<a href="#pone.0330495.ref031" class="usa-link" aria-describedby="pone.0330495.ref031">31</a>] similar to RNAemia, which was also associated with lymphopenia in other studies [<a href="#pone.0330495.ref004" class="usa-link" aria-describedby="pone.0330495.ref004">4</a>,<a href="#pone.0330495.ref005" class="usa-link" aria-describedby="pone.0330495.ref005">5</a>,<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>].</p>
<p>In immunocompromised patients, despite vaccination, the absence of neutralizing antibodies was independently associated with RNAemia. The absence of neutralizing antibodies seems to favor viral dissemination and, in turn, increase tissue damage, which explain the leakage of viral particles and their components from the tissues into the bloodstream [<a href="#pone.0330495.ref035" class="usa-link" aria-describedby="pone.0330495.ref035">35</a>]. This finding was observed in immunocompromised patients as a whole and, specifically, in both SOT recipients and patients with solid neoplasia. In patients with hematological malignancies, with a vaccination rate similar to the other immunocompromised patients, RNAemia was associated with the presence of pneumonia, as previously reported [<a href="#pone.0330495.ref018" class="usa-link" aria-describedby="pone.0330495.ref018">18</a>], but not with the absence of neutralizing antibodies; this fact may be explained by the heterogeneity of diseases included in this type on immunocompromised patients.</p>
<p>Our study has several limitations. Although it was a prospective cohort, inclusion was dependent on having blood samples to evaluate RNAemia after obtaining informed consent from patients. Additionally, the number of patients with mild disease not requiring hospital admission was smaller than the number of patients admitted to the hospital, although more patients had moderate rather than severe disease at the time of blood sampling. Another limitation was the different vaccination rates between immunocompromised patients, who were the first scheduled to receive the vaccine, and immunocompetent patients. Despite these limitations, the strength of this study lies in the multicenter design of our cohort, which was recruited from six Spanish hospitals. Each hospital had its own clinical practice and protocols, although the clinical practice was similar because all followed common national and international guidelines, confirmed by comparing the treatments received by patients with severe and mild patients. Immunocompromised and immunocompetent patients with clinically severe COVID-19, which has previously been associated with RNAemia [<a href="#pone.0330495.ref004" class="usa-link" aria-describedby="pone.0330495.ref004">4</a>,<a href="#pone.0330495.ref006" class="usa-link" aria-describedby="pone.0330495.ref006">6</a>,<a href="#pone.0330495.ref009" class="usa-link" aria-describedby="pone.0330495.ref009">9</a>], were treated more frequently with tocilizumab and dexamethasone at the discretion of the physicians in charge. Finally, the present study has not considered the possible viral and bacterial co-infections [<a href="#pone.0330495.ref036" class="usa-link" aria-describedby="pone.0330495.ref036">36</a>]. However, the accuracy of co-infections diagnosis in the viral community-acquired respiratory infections, including pneumonia, is a difficult issue because of the lack of specificity of many bacterial isolates from respiratory clinical samples. A study on 50,419 upper respiratory samples, positive for SARS-CoV-2, detected 4% and 33% of viral and bacterial co-infections, respectively, but without expressing the method to differentiate <em>Staphylococcus aureus</em> or <em>Haemophilus influenzae</em> detection, as examples, from asymptomatic carriers [<a href="#pone.0330495.ref037" class="usa-link" aria-describedby="pone.0330495.ref037">37</a>]. In addition, a review of 13 studies disclosed a wide co-infection and secondary infection rates in SARS-CoV-2 infection, from 0.6% to 45.0% [<a href="#pone.0330495.ref038" class="usa-link" aria-describedby="pone.0330495.ref038">38</a>], which denotes the very different criteria for diagnostic specificity used in the different studies.</p></section><section id="sec017"><h2 class="pmc_sec_title">Conclusions</h2>
<p>The results of this study show that the main factor determining the presence of SARS-CoV-2 RNAemia at COVID-19 diagnosis depends on underlying conditions such as immunodeficiency, with RNAemia rates almost three times higher in this population than those in immunocompetent individuals. Pneumonia and absence of neutralizing antibodies in immunocompromised patients, biomarkers of tissue damage as LDH in all patients, and lymphopenia in immunocompetent patients were also associated with bloodstream dissemination of the virus. These data highlight the need for quick detection of SARS-CoV-2 RNAemia for early initiation of antiviral treatment, especially in the most vulnerable populations, as RNAemia is associated with poor clinical outcomes. The efficacy of antiviral treatments, through clinical studies, must consider the different demographics features and chronic underlying diseases of patients.</p></section><section id="sec018"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330495.s001"><div class="caption p">
<span>S1. Additional supporting information may be found online in the Supporting Information section.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370080/bin/pone.0330495.s001.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330495.s001.docx</a><sup> (148KB, docx) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the paper and its <a href="#sec018" class="usa-link">Supporting Information</a> files.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This study was supported by Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (REIPI, RD16/0016/0001 [JR-B, BG-G], RD16/0016/0005 [NS], and RD16/0016/0009 [JP, EC, JSC]), co-financed by European Development Regional Fund “A way to achieve Europe”, Operative Program Intelligence Growth 2014-2020. EC, JS-C, JR-B and MA-G received grants from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Proyectos de Investigación sobre el SARS-CoV-2 y la enfermedad COVID-19 (COV20/00370, COV20/00580, COV20/01031) and Acción Estratégica en Salud (PI21/01569). EC and JSC also were supported by the grant IM22/INF/13 from the CIBERINFEC, Instituto de Salud Carlos III, Spain. This study was also supported by CIBERINFEC - Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU (JS-C, EC, CI-D, RA-M, MA-G, SS-A, and JMC, CB21/13/00006; BG-G and JRB, CB/21/13/00012; JC, CB21/13/00009). JME is supported by a grant from the ISCIII (FI22/00025). The funders have not role nor any influence on the design, data analysis or interpretation.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330495.ref001">
<span class="label">1.</span><cite>WHO. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. [WHO Coronavirus (COVID-19) Dashboard With Vaccination Data]. 2023. <a href="https://covid19.who.int/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://covid19.who.int/</a></cite>
</li>
<li id="pone.0330495.ref002">
<span class="label">2.</span><cite>Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol. 2022;32(4):e2313. doi: 10.1002/rmv.2313

</cite> [<a href="https://doi.org/10.1002/rmv.2313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8646685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34755408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Med%20Virol&amp;title=Covid-19%20vaccines%20and%20variants%20of%20concern:%20A%20review&amp;author=I%20Hadj%20Hassine&amp;volume=32&amp;issue=4&amp;publication_year=2022&amp;pmid=34755408&amp;doi=10.1002/rmv.2313&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref003">
<span class="label">3.</span><cite>Tang K, Wu L, Luo Y, Gong B. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J Med Virol. 2021;93(5):3165–75. doi: 10.1002/jmv.26876

</cite> [<a href="https://doi.org/10.1002/jmv.26876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8014647/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33590923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Virol&amp;title=Quantitative%20assessment%20of%20SARS-CoV-2%20RNAemia%20and%20outcome%20in%20patients%20with%20coronavirus%20disease%202019&amp;author=K%20Tang&amp;author=L%20Wu&amp;author=Y%20Luo&amp;author=B%20Gong&amp;volume=93&amp;issue=5&amp;publication_year=2021&amp;pages=3165-75&amp;pmid=33590923&amp;doi=10.1002/jmv.26876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref004">
<span class="label">4.</span><cite>Rodríguez-Serrano DA, Roy-Vallejo E, Zurita Cruz ND, Martín Ramírez A, Rodríguez-García SC, Arevalillo-Fernández N, et al. Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci Rep. 2021;11(1):13134. doi: 10.1038/s41598-021-92497-1

</cite> [<a href="https://doi.org/10.1038/s41598-021-92497-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8222315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34162948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Detection%20of%20SARS-CoV-2%20RNA%20in%20serum%20is%20associated%20with%20increased%20mortality%20risk%20in%20hospitalized%20COVID-19%20patients&amp;author=DA%20Rodr%C3%ADguez-Serrano&amp;author=E%20Roy-Vallejo&amp;author=ND%20Zurita%20Cruz&amp;author=A%20Mart%C3%ADn%20Ram%C3%ADrez&amp;author=SC%20Rodr%C3%ADguez-Garc%C3%ADa&amp;volume=11&amp;issue=1&amp;publication_year=2021&amp;pages=13134&amp;pmid=34162948&amp;doi=10.1038/s41598-021-92497-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref005">
<span class="label">5.</span><cite>Rizzi M, Patrucco F, Trevisan M, Faolotto G, Mercandino A, Strola C, et al. Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients. Panminerva Med. 2022;64(4):465–71. doi: 10.23736/S0031-0808.22.04705-X

</cite> [<a href="https://doi.org/10.23736/S0031-0808.22.04705-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35713624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Panminerva%20Med&amp;title=Baseline%20plasma%20SARS-CoV-2%20RNA%20detection%20predicts%20an%20adverse%20COVID-19%20evolution%20in%20moderate%20to%20severe%20hospitalized%20patients&amp;author=M%20Rizzi&amp;author=F%20Patrucco&amp;author=M%20Trevisan&amp;author=G%20Faolotto&amp;author=A%20Mercandino&amp;volume=64&amp;issue=4&amp;publication_year=2022&amp;pages=465-71&amp;pmid=35713624&amp;doi=10.23736/S0031-0808.22.04705-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref006">
<span class="label">6.</span><cite>Bermejo-Martin JF, González-Rivera M, Almansa R, Micheloud D, Tedim AP, Domínguez-Gil M, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020;24(1):691. doi: 10.1186/s13054-020-03398-0

</cite> [<a href="https://doi.org/10.1186/s13054-020-03398-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7734467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33317616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Viral%20RNA%20load%20in%20plasma%20is%20associated%20with%20critical%20illness%20and%20a%20dysregulated%20host%20response%20in%20COVID-19&amp;author=JF%20Bermejo-Martin&amp;author=M%20Gonz%C3%A1lez-Rivera&amp;author=R%20Almansa&amp;author=D%20Micheloud&amp;author=AP%20Tedim&amp;volume=24&amp;issue=1&amp;publication_year=2020&amp;pages=691&amp;pmid=33317616&amp;doi=10.1186/s13054-020-03398-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref007">
<span class="label">7.</span><cite>Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, et al. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. 2021;7(48):eabj5629. doi: 10.1126/sciadv.abj5629

</cite> [<a href="https://doi.org/10.1126/sciadv.abj5629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8626074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34826237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Adv&amp;title=Integrated%20immunovirological%20profiling%20validates%20plasma%20SARS-CoV-2%20RNA%20as%20an%20early%20predictor%20of%20COVID-19%20mortality&amp;author=E%20Brunet-Ratnasingham&amp;author=SP%20Anand&amp;author=P%20Gantner&amp;author=A%20Dyachenko&amp;author=G%20Moquin-Beaudry&amp;volume=7&amp;issue=48&amp;publication_year=2021&amp;pmid=34826237&amp;doi=10.1126/sciadv.abj5629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref008">
<span class="label">8.</span><cite>Wang C, Li Y, Kaplonek P, Gentili M, Fischinger S, Bowman KA, et al. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia. mBio. 2022;13(4):e0157722. doi: 10.1128/mbio.01577-22

</cite> [<a href="https://doi.org/10.1128/mbio.01577-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9426503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35762593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=mBio&amp;title=The%20Kinetics%20of%20SARS-CoV-2%20Antibody%20Development%20Is%20Associated%20with%20Clearance%20of%20RNAemia&amp;author=C%20Wang&amp;author=Y%20Li&amp;author=P%20Kaplonek&amp;author=M%20Gentili&amp;author=S%20Fischinger&amp;volume=13&amp;issue=4&amp;publication_year=2022&amp;pmid=35762593&amp;doi=10.1128/mbio.01577-22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref009">
<span class="label">9.</span><cite>Salto-Alejandre S, Carretero-Ledesma M, Camacho-Martínez P, Berastegui-Cabrera J, Infante C, Rodríguez-Álvarez R, et al. Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients. J Infect. 2023;86(5):529–33. doi: 10.1016/j.jinf.2023.01.019

</cite> [<a href="https://doi.org/10.1016/j.jinf.2023.01.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9859635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36690212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect&amp;title=Serum%20IFN-%CE%B3%20and%20RNAemia%20temporal%20profiles%20as%20biomarkers%20of%20severe%20COVID-19%20in%20solid%20organ%20transplant%20and%20immunocompetent%20patients&amp;author=S%20Salto-Alejandre&amp;author=M%20Carretero-Ledesma&amp;author=P%20Camacho-Mart%C3%ADnez&amp;author=J%20Berastegui-Cabrera&amp;author=C%20Infante&amp;volume=86&amp;issue=5&amp;publication_year=2023&amp;pages=529-33&amp;pmid=36690212&amp;doi=10.1016/j.jinf.2023.01.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref010">
<span class="label">10.</span><cite>Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584(7821):437–42. doi: 10.1038/s41586-020-2456-9

</cite> [<a href="https://doi.org/10.1038/s41586-020-2456-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7442695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32555388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Convergent%20antibody%20responses%20to%20SARS-CoV-2%20in%20convalescent%20individuals&amp;author=DF%20Robbiani&amp;author=C%20Gaebler&amp;author=F%20Muecksch&amp;author=JCC%20Lorenzi&amp;author=Z%20Wang&amp;volume=584&amp;issue=7821&amp;publication_year=2020&amp;pages=437-42&amp;pmid=32555388&amp;doi=10.1038/s41586-020-2456-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref011">
<span class="label">11.</span><cite>Maciola AK, La Raja M, Pacenti M, Salata C, De Silvestro G, Rosato A, et al. Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition. Front Immunol. 2022;13:830710. doi: 10.3389/fimmu.2022.830710

</cite> [<a href="https://doi.org/10.3389/fimmu.2022.830710" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8841804/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35173741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Neutralizing%20Antibody%20Responses%20to%20SARS-CoV-2%20in%20Recovered%20COVID-19%20Patients%20Are%20Variable%20and%20Correlate%20With%20Disease%20Severity%20and%20Receptor-Binding%20Domain%20Recognition&amp;author=AK%20Maciola&amp;author=M%20La%20Raja&amp;author=M%20Pacenti&amp;author=C%20Salata&amp;author=G%20De%20Silvestro&amp;volume=13&amp;publication_year=2022&amp;pages=830710&amp;pmid=35173741&amp;doi=10.3389/fimmu.2022.830710&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref012">
<span class="label">12.</span><cite>Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12(1):2670. doi: 10.1038/s41467-021-22958-8

</cite> [<a href="https://doi.org/10.1038/s41467-021-22958-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8113594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33976165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Neutralizing%20antibody%20responses%20to%20SARS-CoV-2%20in%20symptomatic%20COVID-19%20is%20persistent%20and%20critical%20for%20survival&amp;author=S%20Dispinseri&amp;author=M%20Secchi&amp;author=MF%20Pirillo&amp;author=M%20Tolazzi&amp;author=M%20Borghi&amp;volume=12&amp;issue=1&amp;publication_year=2021&amp;pages=2670&amp;pmid=33976165&amp;doi=10.1038/s41467-021-22958-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref013">
<span class="label">13.</span><cite>Eberhardt KA, Meyer-Schwickerath C, Heger E, Knops E, Lehmann C, Rybniker J, et al. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients. Viruses. 2020;12(9):1045. doi: 10.3390/v12091045

</cite> [<a href="https://doi.org/10.3390/v12091045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7551174/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32962125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Viruses&amp;title=RNAemia%20Corresponds%20to%20Disease%20Severity%20and%20Antibody%20Response%20in%20Hospitalized%20COVID-19%20Patients&amp;author=KA%20Eberhardt&amp;author=C%20Meyer-Schwickerath&amp;author=E%20Heger&amp;author=E%20Knops&amp;author=C%20Lehmann&amp;volume=12&amp;issue=9&amp;publication_year=2020&amp;pages=1045&amp;pmid=32962125&amp;doi=10.3390/v12091045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref014">
<span class="label">14.</span><cite>Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626–36. doi: 10.1038/s41577-021-00592-1

</cite> [<a href="https://doi.org/10.1038/s41577-021-00592-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8351583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34373623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=Progress%20of%20the%20COVID-19%20vaccine%20effort:%20viruses,%20vaccines%20and%20variants%20versus%20efficacy,%20effectiveness%20and%20escape&amp;author=JS%20Tregoning&amp;author=KE%20Flight&amp;author=SL%20Higham&amp;author=Z%20Wang&amp;author=BF%20Pierce&amp;volume=21&amp;issue=10&amp;publication_year=2021&amp;pages=626-36&amp;pmid=34373623&amp;doi=10.1038/s41577-021-00592-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref015">
<span class="label">15.</span><cite>Liu BM, Yao Q, Cruz-Cosme R, Yarbrough C, Draper K, Suslovic W, et al. Genetic Conservation and Diversity of SARS-CoV-2 Envelope Gene Across Variants of Concern. J Med Virol. 2025;97(1):e70136. doi: 10.1002/jmv.70136

</cite> [<a href="https://doi.org/10.1002/jmv.70136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12228529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39744807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Virol&amp;title=Genetic%20Conservation%20and%20Diversity%20of%20SARS-CoV-2%20Envelope%20Gene%20Across%20Variants%20of%20Concern&amp;author=BM%20Liu&amp;author=Q%20Yao&amp;author=R%20Cruz-Cosme&amp;author=C%20Yarbrough&amp;author=K%20Draper&amp;volume=97&amp;issue=1&amp;publication_year=2025&amp;pmid=39744807&amp;doi=10.1002/jmv.70136&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref016">
<span class="label">16.</span><cite>McCABE WR. Gram-Negative Bacteremia. Arch Intern Med. 1962;110(6):847. doi: 10.1001/archinte.1962.03620240029006</cite> [<a href="https://doi.org/10.1001/archinte.1962.03620240029006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Intern%20Med&amp;title=Gram-Negative%20Bacteremia&amp;author=WR%20McCABE&amp;volume=110&amp;issue=6&amp;publication_year=1962&amp;pages=847&amp;doi=10.1001/archinte.1962.03620240029006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref017">
<span class="label">17.</span><cite>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–7. doi: 10.1016/S1473-3099(20)30483-7

</cite> [<a href="https://doi.org/10.1016/S1473-3099(20)30483-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7292605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32539990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect%20Dis&amp;title=A%20minimal%20common%20outcome%20measure%20set%20for%20COVID-19%20clinical%20research&amp;volume=20&amp;issue=8&amp;publication_year=2020&amp;pmid=32539990&amp;doi=10.1016/S1473-3099(20)30483-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref018">
<span class="label">18.</span><cite>Martín-Escolano J, Salto-Alejandre S, Infante-Domínguez C, Carretero-Ledesma M, Maldonado-Lizarazo N, Camacho-Martínez P, et al. COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients. Int J Infect Dis. 2024;146:107163. doi: 10.1016/j.ijid.2024.107163

</cite> [<a href="https://doi.org/10.1016/j.ijid.2024.107163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38969329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Infect%20Dis&amp;title=COVID-19%20in%20patients%20with%20haematologic%20malignancies:%20Effect%20of%20RNAemia%20on%20clinical%20outcome%20in%20vaccinated%20patients&amp;author=J%20Mart%C3%ADn-Escolano&amp;author=S%20Salto-Alejandre&amp;author=C%20Infante-Dom%C3%ADnguez&amp;author=M%20Carretero-Ledesma&amp;author=N%20Maldonado-Lizarazo&amp;volume=146&amp;publication_year=2024&amp;pages=107163&amp;pmid=38969329&amp;doi=10.1016/j.ijid.2024.107163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref019">
<span class="label">19.</span><cite>Salto-Alejandre S, Roca-Oporto C, Martín-Gutiérrez G, Avilés MD, Gómez-González C, Navarro-Amuedo MD, et al. A quick prediction tool for unfavourable outcome in COVID-19 inpatients: Development and internal validation. J Infect. 2021;82(2):e11–5. doi: 10.1016/j.jinf.2020.09.023

</cite> [<a href="https://doi.org/10.1016/j.jinf.2020.09.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7518180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32987098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect&amp;title=A%20quick%20prediction%20tool%20for%20unfavourable%20outcome%20in%20COVID-19%20inpatients:%20Development%20and%20internal%20validation&amp;author=S%20Salto-Alejandre&amp;author=C%20Roca-Oporto&amp;author=G%20Mart%C3%ADn-Guti%C3%A9rrez&amp;author=MD%20Avil%C3%A9s&amp;author=C%20G%C3%B3mez-Gonz%C3%A1lez&amp;volume=82&amp;issue=2&amp;publication_year=2021&amp;pmid=32987098&amp;doi=10.1016/j.jinf.2020.09.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref020">
<span class="label">20.</span><cite>Spanish Health Ministry. Actualización de la situación epidemiológica de las variantes de SARS-CoV-2 en España. <a href="https://www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Actualizacion_variantes_20230703.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Actualizacion_variantes_20230703.pdf</a></cite>
</li>
<li id="pone.0330495.ref021">
<span class="label">21.</span><cite>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi: 10.1148/radiology.143.1.7063747

</cite> [<a href="https://doi.org/10.1148/radiology.143.1.7063747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7063747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=The%20meaning%20and%20use%20of%20the%20area%20under%20a%20receiver%20operating%20characteristic%20(ROC)%20curve&amp;author=JA%20Hanley&amp;author=BJ%20McNeil&amp;volume=143&amp;issue=1&amp;publication_year=1982&amp;pages=29-36&amp;pmid=7063747&amp;doi=10.1148/radiology.143.1.7063747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref022">
<span class="label">22.</span><cite>Berastegui-Cabrera J, Salto-Alejandre S, Valerio M, Pérez-Palacios P, Revillas FA-DL, Abelenda-Alonso G, et al. SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load. J Infect. 2021;82(3):e38–41. doi: 10.1016/j.jinf.2020.11.024

</cite> [<a href="https://doi.org/10.1016/j.jinf.2020.11.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7688428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33248220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect&amp;title=SARS-CoV-2%20RNAemia%20is%20associated%20with%20severe%20chronic%20underlying%20diseases%20but%20not%20with%20nasopharyngeal%20viral%20load&amp;author=J%20Berastegui-Cabrera&amp;author=S%20Salto-Alejandre&amp;author=M%20Valerio&amp;author=P%20P%C3%A9rez-Palacios&amp;author=FA-DL%20Revillas&amp;volume=82&amp;issue=3&amp;publication_year=2021&amp;pmid=33248220&amp;doi=10.1016/j.jinf.2020.11.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref023">
<span class="label">23.</span><cite>Rombauts A, Infante C, de Lagos MDÁM, Alba J, Valiente A, Donado-Mazarrón C, et al. Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study. J Infect. 2023;86(2):154–225. doi: 10.1016/j.jinf.2022.11.009

</cite> [<a href="https://doi.org/10.1016/j.jinf.2022.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9671615/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36403699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect&amp;title=Impact%20of%20SARS-CoV-2%20RNAemia%20and%20other%20risk%20factors%20on%20long-COVID:%20A%20prospective%20observational%20multicentre%20cohort%20study&amp;author=A%20Rombauts&amp;author=C%20Infante&amp;author=MD%C3%81M%20de%20Lagos&amp;author=J%20Alba&amp;author=A%20Valiente&amp;volume=86&amp;issue=2&amp;publication_year=2023&amp;pages=154-225&amp;pmid=36403699&amp;doi=10.1016/j.jinf.2022.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref024">
<span class="label">24.</span><cite>Hogan CA, Stevens BA, Sahoo MK, Huang C, Garamani N, Gombar S, et al. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clin Infect Dis. 2021;72(9):e291–5. doi: 10.1093/cid/ciaa1054

</cite> [<a href="https://doi.org/10.1093/cid/ciaa1054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7543277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32965474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=High%20Frequency%20of%20SARS-CoV-2%20RNAemia%20and%20Association%20With%20Severe%20Disease&amp;author=CA%20Hogan&amp;author=BA%20Stevens&amp;author=MK%20Sahoo&amp;author=C%20Huang&amp;author=N%20Garamani&amp;volume=72&amp;issue=9&amp;publication_year=2021&amp;pmid=32965474&amp;doi=10.1093/cid/ciaa1054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref025">
<span class="label">25.</span><cite>Andersson MI, Arancibia-Carcamo CV, Auckland K, Baillie JK, Barnes E, Beneke T, et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020;5:181. doi: 10.12688/wellcomeopenres.16002.2

</cite> [<a href="https://doi.org/10.12688/wellcomeopenres.16002.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7689603/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33283055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Wellcome%20Open%20Res&amp;title=SARS-CoV-2%20RNA%20detected%20in%20blood%20products%20from%20patients%20with%20COVID-19%20is%20not%20associated%20with%20infectious%20virus&amp;author=MI%20Andersson&amp;author=CV%20Arancibia-Carcamo&amp;author=K%20Auckland&amp;author=JK%20Baillie&amp;author=E%20Barnes&amp;volume=5&amp;publication_year=2020&amp;pages=181&amp;pmid=33283055&amp;doi=10.12688/wellcomeopenres.16002.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref026">
<span class="label">26.</span><cite>Ram-Mohan N, Kim D, Zudock EJ, Hashemi MM, Tjandra KC, Rogers AJ, et al. SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19. Clin Infect Dis. 2022;74(2):218–26. doi: 10.1093/cid/ciab394

</cite> [<a href="https://doi.org/10.1093/cid/ciab394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8135992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33949665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=SARS-CoV-2%20RNAemia%20Predicts%20Clinical%20Deterioration%20and%20Extrapulmonary%20Complications%20from%20COVID-19&amp;author=N%20Ram-Mohan&amp;author=D%20Kim&amp;author=EJ%20Zudock&amp;author=MM%20Hashemi&amp;author=KC%20Tjandra&amp;volume=74&amp;issue=2&amp;publication_year=2022&amp;pages=218-26&amp;pmid=33949665&amp;doi=10.1093/cid/ciab394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref027">
<span class="label">27.</span><cite>Martín Ramírez A, Zurita Cruz ND, Gutiérrez-Cobos A, Rodríguez Serrano DA, González Álvaro I, Roy Vallejo E, et al. Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis. J Virol Methods. 2022;300:114411. doi: 10.1016/j.jviromet.2021.114411

</cite> [<a href="https://doi.org/10.1016/j.jviromet.2021.114411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8666146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34910983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Virol%20Methods&amp;title=Evaluation%20of%20two%20RT-PCR%20techniques%20for%20SARS-CoV-2%20RNA%20detection%20in%20serum%20for%20microbiological%20diagnosis&amp;author=A%20Mart%C3%ADn%20Ram%C3%ADrez&amp;author=ND%20Zurita%20Cruz&amp;author=A%20Guti%C3%A9rrez-Cobos&amp;author=DA%20Rodr%C3%ADguez%20Serrano&amp;author=I%20Gonz%C3%A1lez%20%C3%81lvaro&amp;volume=300&amp;publication_year=2022&amp;pages=114411&amp;pmid=34910983&amp;doi=10.1016/j.jviromet.2021.114411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref028">
<span class="label">28.</span><cite>Lei C, Lin W, Deng X, Hu F, Chen F, Cai W, et al. Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. J Clin Virol. 2020;133:104661. doi: 10.1016/j.jcv.2020.104661

</cite> [<a href="https://doi.org/10.1016/j.jcv.2020.104661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7554493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33096290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Virol&amp;title=Factors%20associated%20with%20clinical%20outcomes%20in%20patients%20with%20Coronavirus%20Disease%202019%20in%20Guangzhou,%20China&amp;author=C%20Lei&amp;author=W%20Lin&amp;author=X%20Deng&amp;author=F%20Hu&amp;author=F%20Chen&amp;volume=133&amp;publication_year=2020&amp;pages=104661&amp;pmid=33096290&amp;doi=10.1016/j.jcv.2020.104661&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref029">
<span class="label">29.</span><cite>Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443. doi: 10.1136/bmj.m1443

</cite> [<a href="https://doi.org/10.1136/bmj.m1443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7190077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32317267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study&amp;author=S%20Zheng&amp;author=J%20Fan&amp;author=F%20Yu&amp;author=B%20Feng&amp;author=B%20Lou&amp;volume=369&amp;publication_year=2020&amp;pmid=32317267&amp;doi=10.1136/bmj.m1443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref030">
<span class="label">30.</span><cite>Hagman K, Hedenstierna M, Gille-Johnson P, Hammas B, Grabbe M, Dillner J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study. Clin Infect Dis. 2021;73(9):e2995–3001. doi: 10.1093/cid/ciaa1285

</cite> [<a href="https://doi.org/10.1093/cid/ciaa1285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7499508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32856036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20RNA%20in%20Serum%20as%20Predictor%20of%20Severe%20Outcome%20in%20Coronavirus%20Disease%202019:%20A%20Retrospective%20Cohort%20Study&amp;author=K%20Hagman&amp;author=M%20Hedenstierna&amp;author=P%20Gille-Johnson&amp;author=B%20Hammas&amp;author=M%20Grabbe&amp;volume=73&amp;issue=9&amp;publication_year=2021&amp;pmid=32856036&amp;doi=10.1093/cid/ciaa1285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref031">
<span class="label">31.</span><cite>Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020;26(11):1525–36. doi: 10.1016/j.cmi.2020.07.024

</cite> [<a href="https://doi.org/10.1016/j.cmi.2020.07.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7399713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32758659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Microbiol%20Infect&amp;title=Characteristics%20and%20predictors%20of%20death%20among%204035%20consecutively%20hospitalized%20patients%20with%20COVID-19%20in%20Spain&amp;author=J%20Berenguer&amp;author=P%20Ryan&amp;author=J%20Rodr%C3%ADguez-Ba%C3%B1o&amp;author=I%20Jarr%C3%ADn&amp;author=J%20Carratal%C3%A0&amp;volume=26&amp;issue=11&amp;publication_year=2020&amp;pages=1525-36&amp;pmid=32758659&amp;doi=10.1016/j.cmi.2020.07.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref032">
<span class="label">32.</span><cite>Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9(8):1736–42. doi: 10.1183/09031936.96.09081736

</cite> [<a href="https://doi.org/10.1183/09031936.96.09081736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8866602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Respir%20J&amp;title=Usefulness%20of%20lactate%20dehydrogenase%20and%20its%20isoenzymes%20as%20indicators%20of%20lung%20damage%20or%20inflammation&amp;author=M%20Drent&amp;author=NA%20Cobben&amp;author=RF%20Henderson&amp;author=EF%20Wouters&amp;author=M%20van%20Dieijen-Visser&amp;volume=9&amp;issue=8&amp;publication_year=1996&amp;pages=1736-42&amp;pmid=8866602&amp;doi=10.1183/09031936.96.09081736&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref033">
<span class="label">33.</span><cite>Wu M-Y, Yao L, Wang Y, Zhu X-Y, Wang X-F, Tang P-J, et al. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia. Respir Res. 2020;21(1):171. doi: 10.1186/s12931-020-01427-8

</cite> [<a href="https://doi.org/10.1186/s12931-020-01427-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7336103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32631317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respir%20Res&amp;title=Clinical%20evaluation%20of%20potential%20usefulness%20of%20serum%20lactate%20dehydrogenase%20(LDH)%20in%202019%20novel%20coronavirus%20(COVID-19)%20pneumonia&amp;author=M-Y%20Wu&amp;author=L%20Yao&amp;author=Y%20Wang&amp;author=X-Y%20Zhu&amp;author=X-F%20Wang&amp;volume=21&amp;issue=1&amp;publication_year=2020&amp;pages=171&amp;pmid=32631317&amp;doi=10.1186/s12931-020-01427-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref034">
<span class="label">34.</span><cite>Mu T, Wang X, Lu Z, Tong J. Implications of LDH in patients with coronavirus disease 2019 pneumonia. Front Cell Infect Microbiol. 2023;13:1180187. doi: 10.3389/fcimb.2023.1180187

</cite> [<a href="https://doi.org/10.3389/fcimb.2023.1180187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10642759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37965268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Infect%20Microbiol&amp;title=Implications%20of%20LDH%20in%20patients%20with%20coronavirus%20disease%202019%20pneumonia&amp;author=T%20Mu&amp;author=X%20Wang&amp;author=Z%20Lu&amp;author=J%20Tong&amp;volume=13&amp;publication_year=2023&amp;pages=1180187&amp;pmid=37965268&amp;doi=10.3389/fcimb.2023.1180187&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref035">
<span class="label">35.</span><cite>Burton DR. Antiviral neutralizing antibodies: from in vitro to in vivo activity. Nat Rev Immunol. 2023;23(11):720–34. doi: 10.1038/s41577-023-00858-w

</cite> [<a href="https://doi.org/10.1038/s41577-023-00858-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10108814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37069260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=Antiviral%20neutralizing%20antibodies:%20from%20in%20vitro%20to%20in%20vivo%20activity&amp;author=DR%20Burton&amp;volume=23&amp;issue=11&amp;publication_year=2023&amp;pages=720-34&amp;pmid=37069260&amp;doi=10.1038/s41577-023-00858-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref036">
<span class="label">36.</span><cite>Contes KM, Liu BM. Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Pathogens. 2025;14(3):262. doi: 10.3390/pathogens14030262

</cite> [<a href="https://doi.org/10.3390/pathogens14030262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11944763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40137747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathogens&amp;title=Epidemiology,%20Clinical%20Significance,%20and%20Diagnosis%20of%20Respiratory%20Viruses%20and%20Their%20Co-Infections%20in%20the%20Post-COVID%20Era&amp;author=KM%20Contes&amp;author=BM%20Liu&amp;volume=14&amp;issue=3&amp;publication_year=2025&amp;pages=262&amp;pmid=40137747&amp;doi=10.3390/pathogens14030262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref037">
<span class="label">37.</span><cite>Singh V, Upadhyay P, Reddy J, Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int J Infect Dis. 2021;105:617–20. doi: 10.1016/j.ijid.2021.02.087

</cite> [<a href="https://doi.org/10.1016/j.ijid.2021.02.087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7905386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33640570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Infect%20Dis&amp;title=SARS-CoV-2%20respiratory%20co-infections:%20Incidence%20of%20viral%20and%20bacterial%20co-pathogens&amp;author=V%20Singh&amp;author=P%20Upadhyay&amp;author=J%20Reddy&amp;author=J%20Granger&amp;volume=105&amp;publication_year=2021&amp;pages=617-20&amp;pmid=33640570&amp;doi=10.1016/j.ijid.2021.02.087&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330495.ref038">
<span class="label">38.</span><cite>Lai C-C, Wang C-Y, Hsueh P-R. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?. J Microbiol Immunol Infect. 2020;53(4):505–12. doi: 10.1016/j.jmii.2020.05.013

</cite> [<a href="https://doi.org/10.1016/j.jmii.2020.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7245213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32482366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Microbiol%20Immunol%20Infect&amp;title=Co-infections%20among%20patients%20with%20COVID-19:%20The%20need%20for%20combination%20therapy%20with%20non-anti-SARS-CoV-2%20agents?&amp;author=C-C%20Lai&amp;author=C-Y%20Wang&amp;author=P-R%20Hsueh&amp;volume=53&amp;issue=4&amp;publication_year=2020&amp;pages=505-12&amp;pmid=32482366&amp;doi=10.1016/j.jmii.2020.05.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1. Additional supporting information may be found online in the Supporting Information section.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370080/bin/pone.0330495.s001.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330495.s001.docx</a><sup> (148KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data are within the paper and its <a href="#sec018" class="usa-link">Supporting Information</a> files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330495"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330495.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (637.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370080/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370080/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370080%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370080/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370080/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370080/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40839611/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370080/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40839611/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370080/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370080/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ZUtGIyAraBvevEYBzT1Rl1cxXhi9umba47ydyUivlZQt2aJGR4PFqq4w3Vgn5UUL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
